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Resumo
A angiogénese, o processo através do qual novos vasos sanguíneos crescem a
partir da vasculatura pré-existente, é um dos processos centrais subjacentes às re-
des vasculares. Está implicada em mais de 70 doenças até agora, tendo-se tornado
no objecto de estudo de muitos investigadores, no campo da investigação biológica
mas também na área computacional. Sendo que é crucial para o desenvolvimento
de cancros na sua fase vascular, muitos investigadores têm dedicado os últimos 15
anos ao seu estudo, que envolve uma grande quantidade de diferentes factores, na
procura de terapêuticas que eventualmente tenham a angiogénese como alvo.
A angiogénese é um processo biológico complexo. Neste trabalho começa-se por
revêr alguns dos principais mecanismos essenciais para a angiogénese.
Vários modelos matemáticos que modelam a angiogénese combinados com
simulações computacionais têm sido propostos nos últimos 30 anos, alguns em
duas dimensões, os mais recentes em 3D, e considerado vários aspectos diferentes
envolvendo a angiogénese: quimiotaxia, haptotaxia, angiopoietinas e propriedades
da Matriz Extracelular.
Esta tese envolve a simulação de um modelo híbrido multi-escalar de fases que
descreve a dinâmica da interface entre os novos capilares e o estroma. Quatro
equações modelam o comportamento das células endoteliais proliferativas em
resposta a um gradiente de factores pró-angiogénicos (T ), conduzindo a um
crescimento e evolução temporal de uma árvore de vasos sanguíneos a partir de
rebentos que brotam do capilar inicial. Estes novos rebentos são puxados por
células de ponta activas como resultado de processos internos regulatórios, e
movem-se com uma velocidade proporcional ao gradiente de factores angiogénicos.
As fontes de factor pró-angiogénico são células em hipóxia. Este factor difunde-se
através de um sistema tridimensional com a evolução temporal de T e é consumido
por células endoteliais cuja proliferação é governada pelo parâmetro de ordem φ.
Vários parâmetros do modelo foram modificados de forma a verificar a sua
influência na evolução do sistema. Tal como esperado, valores mais elevados
de resposta quimiotáxica conduziram a um aumento do número de ramificações
nos vasos, sendo eles mais finos. Valores mais elevados de taxa de proliferação
conduziram a uma rede mais grossa e ramificada. Valores de células hipóxicas
inicialmente adicionadas ao sistema maiores conduziram, tal como esperado, a
maiores números de ramificações, maior consumo de factor angiogénico, vasos
mais longos e internamente mais proliferativos.
Alguns vídeos foram obtidos e encontram-se no CD em anexo que permite
melhor ilustrar a evolução temporal do sistema nas diversas circunstâncias
testadas.
Palavras-Chave: angiogénese, modelo de interface difusa, tridimensional,
modelacao híbrida, VEGF
Abstract
Sprouting angiogenesis, the process by which new blood vessels grow from
the pre-existing vasculature, is one of the central processes underlying vascular
networks. It is implicated in more than 70 diseases so far, having become the
object of study to many investigators, in the biological research field but also
in the computational area. Since this is crucial for the development of cancers
in its vascular phase, many researchers have dedicated the last 15 years to its
study, which involves a great amount of different factors, in search of therapeutics
eventually targeting angiogenesis.
Angiogenesis is a complex biological process. In this work we start by reviewing
some of the main mechanisms essential to angiogenesis.
Various mathematical models to model angiogenesis combined with com-
putational simulations have been proposed in the last 30 years, some in
two-dimensional approaches, the most recent in 3D, and considering various
different aspects involved in angiogenesis: chemotaxis, haptotaxis, angiopoietins
and properties of the Extracelullar Matrix.
This thesis involves the simulation of a hybrid multi-scale phase-field model
which describes the dynamics of the interface that divides the new capillaries
and the stroma. Four equations model the behaviour of proliferating ECs in
response to a gradient of a pro-angiogenic factor (T ), leading to the growth and
time evolution of a tree of vascular vessels from sprouts that emerge from the
original capillar. These new sprouts are pulled by activated tip cells as a result
of internal regulatory processes, and move with a velocity proportional to the
gradient of angiogenic factors. The sources of pro-angiogenic factor are hypoxic
cells. This factor diffuses throughout a three-dimensional system with the time
evolution of T and is consumed by the ECs whose proliferation is governed by an
order parameter φ.
Several parameters of the model were modified in order to verify their influ-
ence in the evolution of the system. As expected, higher values of chemotactic
response led to an increase of the number of ramifications in the vessels, which
were thinner. Higher values of proliferation rate led to thicker vessels and a more
ramified network. Higher values of hypoxic cells initially added to the system
conducted, as expected, to a higher number of branches, higher angiogenic factor
consumption, longer and internally more proliferative vessels.
Some videos were obtained and are in the CD attached which allow a better il-
lustration of the time evolution of the system in the various studied circumstances.
Keywords: angiogenesis, phase-field model, three-dimensional, hybrid model-
ling, VEGF
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Chapter 1
Introduction
1.1 Objectives and Personal Motivation
One of the main processes regulating the development of vascular networks and
its morphology is sprouting angiogenesis, in which new blood vessels grow from
the pre-existing vasculature [11].
Due to its implication in more than 70 disorders so far, in the past 15 years,
there has been a growing interest in angiogenesis research among investigators
from the biological field, leading scientists to the development of new therapeutic
strategies, either to promote revascularization, to counterbalance or to reduce an
angiogenic switch characteristic of some disorders [12]. In 1980 there were only
40 papers published concerning angiogenesis. In 2010, there were already nearly
6000 [5].
According to the Angiogenesis Foundation, the lives of at least 1 billion people
worldwide could be improved with therapies targeting angiogenesis [5].
In some diseases, the excessive angiogenic stimulus which represents an
uncontrolled process, leads to an enhanced neovascularization as in the case of
inflammatory diseases such as rheumatoid arthritis, autoimmune diseases like
psoriasis, during tumor development and in ocular disorders, as diabetic retinopa-
thy [11]-[13]. These fragile new blood vessels lack vascular smooth muscle cells
and are prone to rupture, remaining susceptible to hypoxic regulation and failing
to become remodeled; these facts may lead to an inability to maintain a proper
circulation [13]. In other disorders, however, there is an insufficient angiogenic
stimulus which has numerous consequences namely the creation of dysfunctional
ECs and vessels, and even the hindrance of vessel formation or healing. Ischaemic
heart disease and preeclampsia are two examples [12].
The main goal of the work developed along the academic year that now reaches
its end, was to computationally simulate the growth and time evolution of a
vascular network in which new blood vessels grow directed by a tip cell according
to the gradient of growth factors. This simulation was developed using Fortran 90
and was based on a phase-field model, fully described on chapter 3.
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Finally, due to the colaboration between the Center for Computational Physics,
through Professor Rui Travasso, and IBILI, the Institute of Biomedical Research
in Light and Image, another goal of this project was conducted: the exchange of
knowledge between the computational and the biological domains.
This thesis is integrated in the project "Angiogenesis in Diabetic Retinopa-
thy: integrating experience and modelling" with reference PTDC/SAU-
ENB/110354/2009, which is based in the interdisciplinarity between these
two subjects.
There was also an initial objective of paralelizing the program or some of its
subroutines with Message Passing Interface. Because of this initial goal, the Par-
allel Computation Classes of the Master Degree in Modulation and Computational
Simulation of Physics were attended. However, because of the evolution of the
project goals throughout the year which focused on the optimization of the pro-
gram which lead to a relatively small amount of time needed for the simulation
and also to the inclusion of other aspects of the process of angiogenesis in the si-
mulation, this goal was excluded, being, however, a future objective.
In the next figure, the general schedule of the project is presented.
Figure 1.1: General schedule of the project.
1. Parallel Computation Classes
2. Program/Simulation Development
3. Bibliographic Research
4. Masther Thesis Elaboration
Chapter 2
Literature Review
2.1 General Aspects
Evolution has determined the existence of vascular systems with different com-
plexities. In primitive species, such as the fruit fly Drosophila melanogaster, due
to its size, anatomy and morphology of its respiratory system, oxygen diffuses
throughout the small body, reaching all cells. In more complex species, which
developed later and reach larger sizes, only the existence of a highly organized
vascular network enables the distribution of oxygen and nutrients to all the cells,
allowing the existence of these animals [12].
The discovery of the vascular system, in which the heart pumps the blood to
all the parts of the body through arteries and to which the blood returns through
veins after irrigating all the cells of every tissue, dates back to 1628, by William
Harvey. Later, in 1661, Marcello Malphighi identified the capillaries as the
smallest vessels existing between arteries and veins [12].
The entire vasculature surface is approximately 1000 m2 and consists of
large arteries which branch to originate pre-capillary arterioles that give rise to
capillaries. The capillaries feed into venules which progressively associate into
larger venous structures [13].
The Scottish anatomist and surgeon John Hunter was, in 1794, the first
scientist to observe the proportionality between vascularity and metabolic re-
quirements, in both health and disease, although the term angiogenesis only
arose in 1935, when Herting described the formation of new blood vessels in the
placenta. In 1971, Folkman studied the neovascularization inherent to the growth
of solid tumors. The modern history of angiogenesis began [5, 13].
In humans, the first blood vessels appear in the embryo through a process
called vasculogenesis, providing nutrition and trophic signals which promote or-
gan morphogenesis. Not only the embryo, but also its extraembryonic membranes
such as the yolk sac, develop during the early stages of life [14]. Capillaries are
needed in all these tissues for exchange of nutrients and metabolites [5].
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Vasculogenesis is the de novo blood vessel generation from vascular progenitor
cells. It is the earliest morphogenetic process of vascular development and
occurs exclusively during the early stages of the embryonic development, being
associated with vascular endothelial progenitor cells [13]. During this process,
endothelial progenitor cells organize themselves in blood clusters, which then fuse
to form the primitive capillary plexus [13, 15].
A primitive vascular labyrinth of small capillaries is then extended as a result
of the angiogenic process, which also involves sprouting, branching, splitting
and differential growth of vessels; pericytes1 and SMC cover the endothelial cell
channels formed during vasculogenesis, resulting in a more complex, larger and
more branched vascular network, that invades target tissues [12]-[15]. There are
several intercellular signaling pathways involved in the processes of vasculoge-
nesis and angiogenesis in mammals. Some of these pathways are the Vascular
Endothelial Growth Factor pathway, the TGF-β pathway, the angiopoietin/Tie
receptor pathway and the ephrin/Eph receptor pathway [14, 17, 18]. ECs are very
versatile, having been observed to form tubular structures and ring type forms,
by Folkman and Haundenschild in 1980, and these tubes were also seen to form a
full network in 14 days [19].
As the embryo grows, some of the vessels originated in the primitive plexus
remain as capillaries but others differentiate into arteries or veins, through a
process which, interestingly, is thought to be intrinsically programmed, in which
ECs, resulting from vasculogenesis, appear to have already at this stage acquired
arterial and venous cell fates [12, 13].
Haemodynamic forces are believed to play a significant role in the processes
of regression and differentiation of vascular vessels. These forces are generated
by blood flow into a capillary segment. When the blood flow ceases and no more
shear stress is exerted on the capillary walls of the vessel, there is a consequent
regression of the vessel. When, instead, there is an increase in the shear stress
and pressure in a vessel due to a greater amount of blood circulation inside it, a
local recruitment of SMCs can lead to the differentiation of a capillary vessel into
an artery or vein [13].
Shear stress or, in other words, haemodynamic forces originated by the blood
flow in a vessel, occur as a molding force in the vasculature since whenever an
arterial occlusion or a slowly progressing stenosis occur, a pressure gradient is
generated along the shortest path in the interconnecting network leading to an
increase in the blood flow velocity and consequently an increase in the fluid shear
stress in these vessels which assume the function of "collaterals" [13]. There is
a relationship between the diameter of an artery and the velocity of the blood
flowing inside it, defined by the embryologist Thoma; any deviation from the
relationship referred causes either vessel growth or its atrophy [13].
1Support cell for ECs that can differentiate into a fibroblast, a SMC or a macrophage [16].
During the process of sprouting angiogenesis, ECs from existing capillaries
suffer a transition in their phenotype to tip cells. These cells detach from the
vessels they were part of and migrate in the direction of the gradient of tissue
produced growth factors. In this migration, another cell’s phenotype, stalk cells,
follow the tip cells [1, 11]. The existence of these two phenotypes of ECs is
functionally fundamental since stalk cells guarantee the non-disintegration of the
vessels and tip cells are essential to the formation of new vessels in the correct
pattern [20].
During this process, vasodilatation, mediated by nitric oxide, occurs, simulta-
neously with an increasing of permeability allowing the extravasation of plasma
proteins which have a relevant role in the migration of ECs [11]. Different
architectures can occur: EC tubes commonly bifurcate and branch, but they
can also fuse together through the anastomoses, establishing a micro-circulatory
network [19].
In adults, angiogenesis occurs during the cycling ovary and pregnancy, in the
placenta, and although ECs remain quiescent, they maintain the ability to divide
rapidly if necessary, and, for example, in wound healing [1, 12, 13].
The process of angiogenesis may be summarized by the following five sequential
steps [19]:
1. The capillary basal lamina dissolves through degradation by proteolytic en-
zymes produced by the filopodia of ECs;
2. ECs migrate and proliferate into connective tissues and the stroma in order
to form sprouts;
3. Sprouts progress and originate the new blood vessels;
4. The basement membrane is resynthesized and the vessels’ lumen is created;
5. A capillary network is originated by the occurence of anastomoses.
Arteriogenesis is the process following angiogenesis and describes the remo-
delling of the pre-existing anastomoses between arteries and arteriolas [21, 22].
This remodeling process includes the rapid proliferation of pre-existing collateral
arteries, which are composed by a tube of ECs, internally covered by an elastic
lamina and externally enfolded by SMCs and that can dramatically increase the
lumen diameter, in an actively proliferation and remodeling process, to allow
a greater perfusion in order to irrigate ischemic regions. These arteries are
essential if an occlusion occurs. In this case, a pressure gradient is generated
along the vessels neighboring the occluded zone that increases the velocity of the
blood flow, causing an increase in the shear stress in these vessels which will, in
these conditions, play the role of the collateral vessels [13, 22]. This process is not
a passive dilatation but an active one [13].
The following image summarizes the three processes involved in the develop-
ment of the vascular networks discussed.
Figure 2.1: Vasculogenesis, Angiogenesis and Arteriogenesis. Vasculogenesis is
characterized by an organization of angioblasts, the ECs precursor cells, angio-
genesis is the process by which new blood vessels grow from the pre-existing vas-
culature and arteriogenesis is defined by a re-organization of the vascular network
with the occurence of a hierarchy [4].
2.2 Biology Background
The proliferation and regression of the vasculature is highly influenced by oxygen,
a central role molecule since it has an extreme importance in the feedback
regulation of these processes [5].
Whenever oxygenation is not sufficient, hypoxic signals trigger or suppress
various proangiogenic or antiangiogenic substances, leading to vascular growth.
Cells begin to receive oxygen through the vasculature meanwhile generated,
either by the increase of both the capillary surface area and maximum blood flow
to the tissues, and also the reduction of the diffusion distances between capillaries
and parenchymal cells. When the tissues receive the oxygen quantities needed,
even during periods of peak metabolic activity, proangiogenic and antiangiogenic
factors return to nearly normal levels, and these negative signals, in turn, stop the
further development of the vasculature, closing the feedback loop. The opposite
process is believed to take place when overoxygenation occurs [5].
The following figure shows the referred loop and in blue and red, the factors
thought to be responsible for hypoxia (leading to vessel growth) and hyperoxia
(leading to vessel regression), respectively [5].
Figure 2.2: Oxygen role in vascular patterning. Hypoxia and hyperoxia states lead
to vascular growth and regression, respectively, in a process in which the tissue
oxygenation is subjected to a negative feedback loop [5].
In normal tissues and in pathological situations that lead to an angiogenic
excessive stimulus, a break in the balance between angiogenic stimulators and
anti-angiogenic factors occurs, which tips in favor of the pro-angiogenic factors.
VEGF is the best characterized pro-angiogenic factor which has a triple role in
its vascular activity [1]:
1. Triggers the capillaries’ permeability with the resulting activation of the tip
cells’ phenotype;
2. Foments the migration of tip cells according to its gradient;
3. Fuels the proliferation of stalk cells.
VEGF-A is produced by several types of parenchymal cells (myocytes, hepa-
tocytes, neurons, astrocytes, etc.) in response to an hypoxic micro-environment [5].
There are various families of VEGF; VEGF-A was the first to be discovered.
VEGF-A was found, in 1992, by Shweiki et al., to be strongly up-regulated in
glial tumor cells exposed to an anoxic environment. This finding was also verified
for in vivo and in vitro tests, and this state was reversed with cells’ exposure to a
non-hypoxic environment [5].
The VEGF ligands can join 3 primary receptors and 2 co-receptors. From the
3 primary receptors, only the VEGFR-1 and VEGFR-2 are associated with an-
giogenesis, VEGFR-3 is associated with lymphangiogenesis. The co-receptors,
NRP-1 and NRP-2 are produced by ECs and are responsible for the increase in the
affinity of the connections between the VEGF ligands and the primary receptors,
although their influence on angiogenesis is still unknown [23].
There are 6 isoforms of human VEGF-1 (another designation for VEGF-A)
known with 121, 145, 165, 183, 189 and 206 amino acids, being the VEGF165,
VEGF121 and VEGF189 the most abundant and all sharing a common characte-
ristic: the affinity to heparin, which is low in VEGF121, moderate in VEGF165
and high in VEGF189. The heparin binding property is important since it
contributes to the anchorage of these VEGF isoforms to the extracellular matrix,
hence contributing to a more active state of these isoforms [23].
VEGF is specific for ECs and is a potent chemoattractant and mitogen [9].
In figure 2.3, four rows are represented that express the various aspects char-
acterizing the process of angiogenesis, where there is an imbalance in angiogenic
factors favoring the pro-angiogenic factors side [6].
The first row compares the structure and functionality of normal and abnormal
vasculature, for example a normal situation and a tumor vasculature. The
second row of two-photon images shows that in the abnormal situation, a human
carcinoma in mice, the vasculature is much more developed, showing that the
pro-angiogenic stimulus created by the tumor hypoxic cells led to the increase in
the vasculature in the vicinity of the tumor. Finally, the last two rows of figures
show that there is an irregular deposition of pericytes in the abnormal vasculature
when compared to the normal situation, which obviously, is due to the imbalance
shown in the last row of figures [6].
Figure 2.3: Normal and abnormal angiogenesis. Normal and abnormal angiogen-
esis differ on the organization of the vessels in arteries that ramify in arterio-
las, which then ramify into capillaries, feeding into venules and, finally, veins;
the blood flow is considerably increased in the abnormal situation in which there
is also an irregular deposition of perycites due to the imbalance in the anti and
proangiogenic stimuli [6].
VEGF is counterbalanced by angiogenic inhibitors as thrombospondin-1 2 [6].
VEGF is detected by tip cells, the cells that pull new blood vessels, through
their filopodia. Tip cell filopodia have three functions [24]:
• intercellular communication;
• cell migration;
• cell adhesion.
Filopodia exist in a various number of cells and play different roles, from the
migration orientation in the growth cone of neurons to the signalling between
cells in Drosophila. In endothelial cells, filopodia existing in tips are used to
sense the VEGF gradient which tip cells follow and it is also probable that they
use filopodia to attach to astrocytes or astrocyte-derived matrix (in retina) which
produce a gradient of VEGF [24].
When there are enough filopodia on a tip cell anchored to the substratum,
filopodia filaments of actin contract pulling the tip cell towards the VEGF stim-
ulus. The proliferation of stalk cells and development of vacuoles within these
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cells, lead to the elongation of the capillaries. When the tip cells of two or more
capillary sprouts converge at the source of VEGF-A secretion (the hypoxic cell),
the tip cells fuse together creating a continuous lumen which is able to allow the
flow of oxygenated blood [5].
Gerhardt, et al, propose that tip cell filopodia extend on VEGF producing
astrocytes and that VEGF-A stimulates tip cell filopodia, since the VEGF over-
expression induces the extension of the filopodia, as well as vascular sprouting
and also the hyperfusion of vessels in which the referred processes had already
stopped. It is also, however, suggested by the authors that is is not clear whether
if filopodial extension is regulated by VEGF or if it is an inherent characteristic of
the tip cell phenotype, induced by VEGF [24].
Another important fact that relates VEGF and endothelial cell filopodia is
that there is an increase of VEGFR2 on the filopodia of tip cells which is believed
to be implicated in filopodia protrusion. It is concluded that the extension and
maintenance of the filopodia existing in tip cells depends on VEGF-A signalling
through VEGFR2 [24].
The important difference between the angiogenic stimulus in normal tissues
and in pathological conditions is that in the second case the imbalance persists,
there is a continuous production of VEGF and also of the proliferation of new
blood vessels [1, 6].
The process of angiogenesis requires a very strict regulation of signals and,
although VEGF is the pro-angiogenic factor to which more emphasis is given since
it is included in the simulation, various other factors are essential to this process
to occur correctly [1].
In some cancer types, for example, the central region of the spheroid mass
becomes necrotic due to the the fact that the cells that constitute the interior
part of the tumor are located too far from any blood vessels and the oxygen
deliverage is less than the needed by these highly proliferative cells. In these
cancer cells, apoptotic pathways are inactivated, anti-apoptotic pathways are
activated, or invasion/metastasis pathways that promote escape from the hypoxic
microenvironment are activated [25]. The cells that surround that area, still
living cells, although hypoxic, may trigger a cascade of HIF-1 and VEGF mediated
events that promote the vascularization of the tumor area through angiogenesis.
HIF activation upregulates VEGF-A and its receptors VEGFR1 and VEGFR2 [20].
HIF is, so, another very important factor involved in angiogenesis [20].
Angiogenesis requires, as well, the degradation of the vascular basement
membrane which occurs between the epithelial tissue and the connective tissue,
so that ECs can migrate through the EM [19]. Tip migration is associated
with the production of MMPs, a family of enzymes that proteolytically degrade
components of the EM, which, during angiogenesis, is remodeled in order to
allow the migration of tip cells. Besides this, MMPs also have been shown to
enhance angiogenesis, contributing to the pericyte detachment from vessels
where angiogenesis is occuring and to the release of growth factors bounded to
the EM. MMPs contribute to expose pro-angiogenic binding sites in the EM and
cleaving the adhesions established between contiguous ECs. MMPs can also act
to decrease angiogenesis through the generation of endogenous angiogenesis in-
hibitors [1, 6, 26]. Since the MMPs affect the affinity of VEGF species to different
extracellular locations, this fact underlines the importance of this growth factor
in angiogenesis [1].
Figure 2.4 shows the beginning of the process of sprouting angiogenesis:
the ECs begin to loose the normally tight contacts with neighbouring cells and
filopodia secrete large amounts of proteolytic enzymes; the basement membrane,
the support layer that covers the endothelium, is degraded by these enzymes; tip
cells migrate and penetrate the stroma; filopodia extend and follow the VEGF
gradient during the migration of tip cells [7].
Figure 2.4: Early events of sprouting angiogenesis. The ECM is dissolved, new
sprouts emerge from the original capillary pulled by tip cells in response to a gra-
dient of VEGF produced by hypoxic tumor cells [7].
Tip cells activation is an essential process underlying angiogenesis, since they
pull the new capillaries once activated.
Another important factor for the formation of new blood vessels and their
stabilization is cell-adhesion. The adhesion junctions between contiguous cells
are conducted by cadherins which inhibit the chemotaxis response of ECs to
VEGF-A at the boundaries of two ECs, increasing the stability of those boundaries
[20]. ECs, which like their precursors angioblasts are highly motile, have focal
adhesion sites and can exert traction forces upon the matrix that surrounds
them. Additionaly, they are polarized since they only move in the direction where
filopodia exist. The cell adhesion hinders the motility of some ECs due to the
bonds that exist between them and their neighbours [19].
Finally, two members of the angiopoietin family, Ang-1 and Ang-2, have shown
to have a special role as regulators of angiogenesis. The angiopoietins are ligands
for the tyrosine-kinase receptor that exists in ECs, Tie-2 [9].
Figure 2.5 shows the Tie-2 signalling pathway.
Figure 2.5: Tie-2 signalling pathway. Ang-1 and 2 bind to the tyrosine-kinase
receptor Tie-2 with antagonistic effects, triggering important cell fate signalling
pathways [8].
From this figure we can conclude that the tyrosine-kinase receptor Tie-2, to
which both Ang-1 and Ang-2 bind, with an antagonist effect, triggers various
cellular signalling pathways, such as PI3K/Akt which is extremelly important
for the cell survival since it intervenes in several processes during the cell cycle
as well as the NF-kB pathway, which is crucial during inflammatory processes [27].
Ang-1, which is secreted by peri-endothelial cells (pericytes and SMCs), has
several functions related to angiogenesis [9]:
• maintains cell–cell interactions;
• inhibits apoptosis;
• is involved in the recruitment and sustainablity of support cells such as
CMSs and pericytes, which are characteristic of the vessel maturation pro-
cess;
• mediates interactions between the ECs and the basement membrane.
In embryos deprived of Ang-1 (or of the Tie-2 receptor), vasculogenesis occurs
normally but angiogenesis is perturbed, although leading to the production of new
vessels, they are leaky and inflamed [9].
Administration of Ang-1 causes a reduction on vessel permeability and an
increase in vascular integrity [9].
Ang-2 is an antagonist of Ang-1 which binds the Tie-2 receptor, blocking the
action of Ang-1. When subjected to the presence of Ang-2, cell-cell and cell-matrix
connections are affected, and the basement membrane and the support cells loose
the contact with the endothelium, leading to the occurence of malformations in
the vessels. It is not widely expressed like Ang-1 since its expression is tighly
regulated and is only observed in very strictly located regions where vascular
remodelling is happening. Ang-2 is only expressed when ECs are activated,
which can happen in response to a hypoxic stimulus, being released by the
Weibel–Palade bodies, where it is stored [9, 28].
Ang-1 is, as referred widely expressed and not in response of a stimulus, and
it is, so, responsible for the maintenance of the quiescent state of ECs. This
state is modified with the local and temporal expression of Ang-2, which leads to
a vascular remodelling. The regulatory effect of these angiopoietins is exerted
over ECs in the presence or absence of VEGF. The co-expression of VEGF with
Ang-2 (through binding to Tie-2 receptors) stimulates proliferation whereas in the
absence of VEGF, ECs undergo apoptosis which results in the vessel regression [9].
The next figure schematically summarizes the discussed regulation performed
by Ang-1 and Ang-2, and the effect of the presence and absence of VEGF simulta-
neously with the expression of Ang-2 [9].
Figure 2.6: ECs regulation through Ang-1, Ang-2 and VEGF. Ang-1 is expressed
and produced in a constant pattern by the tissue, whether Ang-2 is produced in
certain circumstances, having a positive or negative effect depending on the VEGF
concentration in the tissue [9].
2.3 The notch signaling pathway
Notch signaling is a relevant pathway to the regulation of cell fate decisions
during the embryonic development of vertebrates and invertebrates, having
been the subject in many studies suggesting to have important roles in various
developmental processes [14, 22]. It was first studied in Drosophila [14].
Some of the processes in which this pathway is involved are apoptosis, differ-
entiation, proliferation and oncogenesis [22].
Four notch genes have been described in mammals, Notch 1-4 and five ligands,
Jagged 1 and 2 and DLL1, DLL3 and DLL4. Both receptors and ligands are
expressed on the cell surface which contributes to notch signaling importance in
the mediation of the comunications between adjacent cells [14, 22].
Notch is a large protein, having a single transmembrane domain which acts
as a receptor for signalling using transmembrane proteins on the surface of
adjacent cells. The stimulation of this pathway whose various sequential steps
are illustrated in the following image, initiates a pathway which consists of
transcriptional activation. Whenever a ligand binds the membrane receptor (the
Delta in the next figure), notch is proteolytically cleaved and its intracellular
domain is translocated into the nucleus. This domain will then interact with a
transcriptional factor, the CSL in mammals, converting it to an activator of its
target genes. The notch signalling pathway targets genes responsible for encoding
other transcriptional regulatory proteins, determinant for cell fate [10].
Figure 2.7: Notch Signalling Pathway. Adjacent cells interact through Delta lig-
ands and the Notch receptor, leading to the nuclear transcription of important cell
phenotype features [10]
In the case of notch signalling during angiogenesis, VEGF can induce the
expression of the DLL4 ligand and the expression of Notch 1 and DLL4 through
the PI3K-Akt pathway in ECs from human vessels. Therefore the activation of
the pathway acts preventing an endothelial cell to adopt the tip cell phenotype if
a tip cell is in its vicinity [1, 22].
Investigation carried out with respect to the embryonic expression of the
Notch4 gene concluded that this gene’s expression is restricted to vascular ECs
and work developed concerning transgenic mouse models and tissue culture
cells has proved that a mammary development is inhibited by the unregulated
expression of the cytoplasmic domain of the Notch4 protein [14]. Studies suggest
a partial functional redundancy of Notch1 and Notch4; although Notch4 gene
is not essential, its mutation genetically interacts with a Notch1 mutation [22, 14].
Various mutations in the notch genes have been documented in the literature
to be involved in pathologies related to vascular development. A mutation in the
Notch3 gene is associated to the human pathology CADASIL, an arteriopathy
which causes stroke and vascular dementia. Also, mice lacking Jagged-1 or
DLL1 were found to be embryonic lethal, showing severe vascular abnormalities.
Furthermore, notch signaling modulates other pathways, namely, the PI3K-Akt
and the NF-kB pathways [14, 22].
Notch has been associated with both oncogenic and tumor suppressive roles
and the existence of different phenotypes of mice used both in knockout and
constitutive expression studies suggests the necessity of an extremelly tight
regulation of this pathway [22].
2.4 Angiogenesis based Therapeutics
Researchers have undertaken intensive efforts to take advantage of the influence
of angiogenesis in several disorders to develop clinical strategies concerning the
pro-angiogenic potential of some growth factors like VEGF [12].
It is suggested that, although angiogenesis does not contribute to the initiation
of a tumor, it is a factor that encourages its growth and, consequently, the
inhibition of angiogenesis reduces the nutrient supply to a tumor, reducing its
growth rate and the risk of metastasis [12, 29].
Due to this fact, scientists have dedicated their research to study various ways
of inhibiting angiogenesis.
Due to the ECs stability, these cells were originally considered as the ideal
target to antiangiogenic drugs, such as VEGF antagonists [12]. Also clinical
trials are nowadays being carried out using inhibitors of MMPs that show an
antiangiogenic action [26].
Avastin R©(bevacizumab) is a Food and Drug Administration (FDA) approved
therapy designed to inhibit angiogenesis developed by Genentech which provides
an overall survival benefit in colorectal, breast and lung cancer patients when
combined with conventional chemotherapy. This drug targets VEGF ligands, thus
contributing to the inhibition of angiogenesis [22, 30].
However, anti-VEGF monotherapy was proved to be ineffective in humans,
although it was effective in rodents; a fact that is still not understood [30].
Although showing promising results in some circumstances, anti-VEGF ther-
apeutics have shown to induce tumor drug resistance after treatment, a process
followed by the promotion of other pro-angiogenic mechanisms, which lead to the
tumor’s development [22].
The notch signaling pathway described in the previous section is another
strategy under investigation by specialists since recent findings indicate a crucial
role of this pathway in tumor angiogenesis, and could represent a novel approach
to the anti-angiogenic therapeutics [22].
2.5 Mathematical Models Overview
In what concerns the computational field, several models concerning the process
of angiogenesis have been presented in the literature, since, in the last 20 years,
this topic has gained interest among the scientific comunity. This growing
interest is strongly motivated by an increase in availability of biological data and
improvement in computational facilities [29, 31].
Models of angiogenesis can be normally classified in the three following types:
continuum, discrete and hybrid models [29, 31].
The continuummodels are used to describe large-scale cell populations through
systems of partial differential equations and, according to these models, capillary
networks are described in terms of endothelial cell densities [29].
Although continuum models provide significant insight into the processes
involving angiogenesis, they are significantly limited in what concerns the pre-
diction of the formation of vascular structures. Vascular networks are described
and presented as tree-like structures where sprouts appear to originate new blood
vessels and, consequently, the models should recognize the existence of separate
sprouts. This distinction is not established by continuum models and, so, a new
model kind arises, the discrete model [29, 31].
Stokes and Lauffenburger were pioneers in describing angiogenesis using
a discrete mathematical model. In their two-dimensional model, sprouts are
defined by the trace of individual tip cells and branching by probabilistic rules.
The migration of tip cells is defined by a stochastic differential equation which
takes into account chemotaxis and random motion [32]. Several models were then
presented in the literature using probabilistic rules to predict the displacement of
tip cells, some in 2D and others, the extensions of those to 3D models [29, 31].
Although more useful when describing vascular structures such as sprouts,
discrete models in which a network of individual space units is defined, represent
an increase in the complexity of a model and time consumption of a simulation
since every individual unit has its own parameters and processes such as prolifer-
ation or diffusion of factors.
Because of the convenience of both kinds of model in the various aspects that
a mathematical modulation requires, hybrid models, combinations of continuum
and discrete models, arose. The mathematical model described in the next chapter,
in which the simulations presented are based, is a hybrid model as it combines
a continuum approximation of angiogenic factors dynamics and endothelial stalk
cell density through proliferation and a discrete representation of tip cells [29, 31].
The following paragraphs will focus on an analysis of the state of the art in
what concerns mathematical models of angiogenesis, some of their differences,
comparisons between them and between the model presented.
Milde F, et al, present a 3D hybrid computational model of sprouting angiogen-
esis that considers both the effects of the EM and of the soluble and matrix-bound
growth factors on the development of the growing capillaries. The authors discuss,
mainly, the association between angiogenesis and tumor growth and proliferation,
and also metastasis ocurrence in consequence of the detachment of tumor cell
clusters’ and migration through the existing vasculature to distant organs. Molec-
ular species are represented by their concentration, migration endothelial tip cells
by particles and new capillaries are represented by the endothelial cell density. In
a very similar way, when compared to our model, the migration of ECs through
the EM follows the chemotactic stimulus and defines the morphology of the newly
formed sprouts. A trail of ECs is left on the 3D system. There are some important
differences between both models since Milde, et al, consider a deposition of ECs
in the EM which leads to the reduction of the diameter of the vessels as they
approach their ends and considers other factors besides VEGF such as fibronectin
(haptotactic response) and MMPs [29].
Holmes MJ and Sleeman BD present a mathematical model in which the
viscoelastic nature of the EM is considered, unlike the models defined by Chaplain
et al. (1995) and Chaplain and Stuart (1991,1993), that simulated the process
of angiogenesis as the diffusion of ECs within a defined region of a passive EM.
This interaction between the EM and the ECs is a very important feature of the
process since it is a mechanism for maintaining endothelial new blood vessels
and also to create the heterogeneous architectures that characterize the vascular
networks [33, 34]. The simulation developed by Holmes MJ and Sleeman BD
was a 2D simulation which considered the equations that describe continuous
quantities, like the endothelial cell density, the EM density, the concentration
of chemo-attractant and the concentration of haptotactic chemical, such as
fibronectin, which is an adhesion mediator that enhances traction capabilities
of ECs, via a system of partial differential equations [9, 19]. One disadvantage
of this modelling approach is its inability to capture microscopic features of the
process such as vessel branching and looping and the morphological properties of
the emerging capillary network, features associated with discrete models [9].
Plank MJ et al. present a continuous 2D mathematical model of tumor
angiogenesis that considers VEGF and the angiopoietins which have already been
exposed in this work as important factors in the regulation of angiogenesis. In this
article, the authors take into account the evolution of some quantities in response
to the presence of a tumor. The EC density, concentration of VEGF and the
concentrations of the angiopoietins 1 and 2 are taken into account in the model.
The model considers that VEGF is produced at a constant rate by the hypoxic cells
of the tumor and that it diffuses through the tissue, establishing a gradient. The
ECs are divided into mature(inactivated) and immature(activated) cells. Although
this assumption represents a simplification of the reality since cells’ maturity
should increase progressively, originating various intermediate maturation states,
the fundamental behaviour is taken into account and can be mathematically
described. Immature cells produce Ang-2, the angiopoietin which is associated
with located areas of high vascullar remodelling. Although the precise stimulus
for Ang-2 expression is unclear, there is increasing evidence that suggests that
Ang-2 is expressed especially at the tips of growing capillaries. The authors also
consider that EC proliferation is confined to immature cells. For the maturation
to take place it is considered that VEGF levels must be above a threshold. In what
concerns Ang-1, the model establishes that it is present throughout the tissue at
a constant level and that it is produced in a proportional fashion along with the
density of mature EC. The action of both the angiopoietins is consistent with what
is already known of their behaviour, and that is summarized in figure 2.6 [9].
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Chapter 3
Description of the Model
3.1 General Aspects
This chapter briefly describes the hybrid model this simulation is based on, cre-
ated by Travasso et al. [1]. Some of the aspects of this model were not considered
in the simulation performed in 3D.
It is a multi-scale phase-field model which describes the dynamics of the
interface that divides the new capillaries and the stroma.
Being a hybrid model of angiogenesis, continuous and discrete methodologies
are underlying its mathematical equations. A discrete approach is concerned in
the model during the description of the phenomena occuring at the cell level, such
as tip cell activation and sprouting of new vessels. The continuum features of
the model consist of the endothelial cell proliferation modelling and the tissue
properties considered [1].
The biological background underlying the model is the same as that on the
basis of this simulation. Blood vessels consist of ECs that have the hability
to proliferate and, during an hypoxic stimulus, change their phenotype to tip
cells in response to the action of internal mechanisms triggered by the referred
environment. These cells lead to the growth of newly formed sprouts from original
capillaries, being followed by stalk cells, the other ECs’ phenotype that does
not interfere with the direction and velocity of the new vessels, but necessarily
proliferate in order to originate the vessel lumen which is essential for blood
circulation to occur. This velocity is proportional to the existence of relevant
growth factors like VEGF which, as a pro-angiogenic factor, leads the evolution
of the process to an increase in the growth of ramifications and the formation of
tree-like structures of capillaries. The action of this factor is counterbalanced by
the action of other factors which instead act as angiogenesis inhibitors. During
the process of angiogenesis, pro-angiogenic factors predominate [1].
Travasso et al. consider also the effect of the extracellular MMPs which,
biologically, act remodeling the nearby EM, affecting the affinity of different
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VEGF species relatively to the extracellular locations, consequently, affecting the
bioavalilability of VEGF. VEGF exists in various isoforms which vary in the way
they establish connections with the EM or with the cell surface, contributing to
affect the vascular patterns [1]. The existence of different VEGF isoforms was not
taken into account in this simulation neither the effect of the MMPs.
Travasso et al. considers the existence of other processes such as anastomoses
[1].
Four equations model the behaviour of proliferating ECs in response to
a gradient of a pro-angiogenic factor, leading to the growth and time evolution
of a tree of vascular vessels from sprouts that emerge from the original capillar [1].
Travasso et al. model does not include the effect of haptotaxis, being the EM
only the medium where ECs migrate with no adhesion sites. The activity of
a balance between pro and anti-angiogenic factors is considered as well as the
MMPs roles. It is a hybrid model which allows a faithful representation of the
proliferation of ECs and the sprouts’ formation, while being fast to integrate
numerically, constituting an advantage over continuous models [1, 29]. The
simulation carried out during this academic year introduces various inovative
aspects. It represents the extension of the model created by Travasso et al. to a
three-dimensional geometry and the program is completely optimized allowing
the achievement of results in a relatively short period of time [1].
Finally, Travasso et al. develop a comparison between the model parameters
and the experimentally measured quantities, an extremely important step in a
simulation of this kind, but outside the scope of this project [1].
3.2 Mathematical Description
The mathematical model and computational simulation is based on four equations.
The first describes the dynamics of a factor T which consists of a balance
between pro and anti-angiogenic factors that tips in favor of the pro-angiogenic
factors, whenever angiogenesis occurs. The pro-angiogenic factor considered is
VEGF. This growth factor is produced by tissue cells in hypoxia and released until
oxygen reaches them through the blood flow inside nearby capillaries. Equation
3.1 describes the time evolution of the concentration of factor T as the combination
of two terms.
∂tT = ∇ · (D∇T )− αT T φΘ(φ), (3.1)
where D is the diffusion constant of the factor T , αT is the angiogenic factor
consumption rate and Θ(φ) is the Heaviside function. D might be considered as
a function if it depends on the type of angiogenic factors considered, since some
of the isoforms attach to heparin, becoming the diffusion constant a function that
depends on the position. This feature is not taken into account in this simulation
but it is present in Travasso et al. modeling.
The Heaviside function takes value 1 when its argument, in this case, φ, is
positive and 0 otherwise, guaranteeing the consumption to exist solely inside the
capillaries. αT is given by
D
R2c
, with Rc the radius of the ECs. The consumption
rate of angiogenic factor depends on the diffusion constant of this factor and on
the radius of the ECs since the capillary wall, composed by these cells, acts as a
barrier to the angiogenic factor leading to the decay of its concentration on the
order of the cell size. The obtention of the expression for αT is achieved from the
stationary solution of equation 3.2 close to the capillary boundary (see Appendix
A).
This equation can be transformed into the simpler next expression, due to the
fact that D is constant. The explanation and deduction are described in Appendix
B.
∂tT = D∇
2T − αT T φΘ(φ), (3.2)
φ is the order parameter which distinguishes two distinct phases: the one that
represents the interior of the capillary and the other that consists of the matrix
outside the capillary. Initially, the capillary, with φ = 1, corresponds to an
aggregate of proliferative cells, the stalk cells, while at the outside of the capillary
where φ = −1, the cells are non-activated. The capillary wall separates these two
phases thus having φ = 0.
The time evolution of the order parameter φ is defined by the equation that
follows from the deduction presented in Appendix C:
∂tφ = M ∇
2 [−φ+ φ3 − ∇2φ] + αp (T )φΘ(φ), (3.3)
where M is the ECs’ mobility coefficient,  is the width of the capillary wall
and αp(T ) defines the proliferation rate of ECs. The right side of the equation
is composed by two terms: the first is responsible for the maintenance of an
interface that separates the two phases, the inside and the outside of the capillary.
Because of the second term of this side of the equation, which describes the ECs’
proliferation, the first term while allowing their proliferation, still assures the
maintenance of a stable interface.
The proliferation rate αp(T ) depends on the value of T at every point of the
system. For the points where T < Tp, this rate is given by αp T and, when T > Tp
this rate reaches its highest value, αpTp.
During the time evolution of the simulation, inside the capillary, φ maintains
positive values, mainly because the capillary wall is defined by φ = 0 and as an
outcome of the interface dynamics term, which, as time evolves, contributes for
the widening of the capillar. Only inside the capillary, equation 3.1 maintains the
second term of the right side, as the Heaviside function becomes 0 when φ < 0.
Consequently, outside the capillary, equation 3.1 simply becomes:
∂tT = D∇
2T, (3.4)
which leads to the conclusion that, outside the capillar, the factor T diffuses over
time through the system’s geometry.
When φ > 0, inside the capillary, the factor T also diffuses but is consumed
at a rate αT and with the consumption depending, also, on the concentration of
T already existing and the concentration of the proliferative ECs, represented by φ.
A new sprout occurs from the original capillar, when some conditions are
satisfied. These conditions will be fully clarified in the next section, where the
computational approach to the model is presented and discussed. However,
biologically, tip cells only acquire this phenotype whenever there are growth
factors in their vicinity and they establish a gradient which allows the tip cell to
move. Because of the notch pathway, only cells with no tip cells close to them can
suffer this alteration of phenotype and become tip cells.
The activated tip cells, that will be the pulling force of new sprouts, move under
the influence of a process called chemotaxis, with the velocity of their movement
being proportional to the gradient of angiogenic factor, ∇T [1].
The next equation of the model describes the velocity of the tip cells:
ν = χ∇T, (3.5)
where χ is the chemotactic response of the ECs. In Travasso et al., this velocity
was given by a more complex expression that considered the existence of a
maximum value to the velocity. However, the results demonstrated a very small
influence of the part of this equation that included the existence of a maximum
value. Consequently, a simpler version of the velocity’s expression was used in
this simulation.
The last equation respects to the phase-field parameter φ of the tip cells. Since
the value of this parameter is defined for the center of the tip cell, the parameter
represents the evolution of the proliferation of the stalk cells in the neighborhood
of the tip cells.
The tip cells are the ECs that have the ability to move during angiogenesis,
producing an excess in cell density through their proliferation which is extended
to the path they travel. This cell density obviously depends on the velocity of each
tip cell moving and evolves in an inversily proportional way with this velocity.
The expression of the parameter φ developed by the tip cells is:
φc =
4αp(T )Rc
3|ν|
, (3.6)
where αp(T ) defines the proliferation rate of endothelial cells, Rc is cell radius
and |ν| is the absolute value of the velocity of the tip cells.
Appendix D presents the explanation that leads to the deduction of the previ-
ous equation.
3.3 Computational Approach
The 3D system considered in the simulation has a geometry of 60x100x100 and
periodic boundary conditions.
An initial capillar was created defining the initial conditions to the order
parameter φ. The values of φ were initially defined as 1 inside the capillar and
-1 outside the capillar. The capillar radius was defined with the value of 5 and
the vessel was aligned in the z direction, having a central axis characterized by
x = y = 50.
In what concerns the initial conditions for the angiogenic factor T , 1000
angiogenic factor sources were initially randomly added to the system. Some of
these were then withdrawn due to the fact that their position was in the oxygen
diffusion area (they were positioned in the vascular network in a place at less
than a distance of d from the original capillar) and they could not, consequently,
represent hypoxic cells.
The values of φ and T were stored in two matrices with the same names. The
coordinates of the hypoxic cells were registered in the fontes matrix.
Depending on the distance of these sources of angiogenic factor, hypoxic cells,
to vessels, they will be kept and some will be withdrawn since the proximity to
the oxygen existing inside nearby vessels reaches these cells satisfying their needs.
For all the positions of every point with φ > 0.9 of the system (representing
regions where blood is flowing), the distances to all the sources of angiogenic
factor are calculated. In this step, one has to be careful with the implemented
boundary conditions, which represent "mirror reflections" of the sources. If the
smaller distance between the system point and the " reflections" of the hypoxic
cell under analysis is less than the value of d, the production of this hypoxic cell is
"turned off".
For every unit of the vascular network that is not a tip cell already chosen
according to the conditions explained later in this report, an update in its values
of T and φ is performed according to equations 3.2 and 3.3. In order to obtain
the updated value of T in this point, the value of the diffusion constant D must
be already defined. The laplacian of T is calculated using the discrete laplacian
expression which consists in the quotient of the sum of the values of T (x+ δx) and
T (x − δx) minus twice the value of the value of T (x) in the point itself, and the
square of δx for all the three dimensions of the system: x, y and z. This expression
was obtained using the Taylor series. Appendix E presents the deduction of this
equation. The values of δx, δy and δz were defined as 1.
The final value of the updated T is obtained using the subtraction between the
product of D by the laplacian of T , the product of the angiogenic consumption rate
by the value of T , the value of φ and the Heaviside function which, as already
referred, takes value of 1 when its argument is positive and 0 otherwise. Updated
values of T of points outside the capillar, which have negative values of φ will con-
sequently only suffer the influence of the first term of the right side of the equation.
The updated value of φ of this vascular network unit is obtained modelling
equation 3.3 where the laplacian of φ, the laplacian of φ3 and the laplacian of
the laplacian (the biharmonic operator) of φ is also obtained following the same
procedure as developed for the calculation of the updated value of T . The first
term of the right side of the equation refers to the interface dynamics as discussed
when the model was presented and the second term refers to the proliferation
of stalk cells, which depends on the proliferation rate of these cells, the value of
φ, this is, the amount of cells already existing in that point and the Heaviside
function which guarantees that the second term of the right side of the equation
is equal to 0 outside the capillar, where there are no ECs proliferating. The
proliferation rate of the stalk cells depends on the value of angiogenic factor which
has the fueling of the stalk cells proliferation as an important function [1].
For all the angiogenic sources that are located at a distance higher than d from
a place where there is capillar, the value of T is set to 1 since they remain as
hypoxic cells.
The time of execution of the program was defined to be limited at a value of
22.5 and the time step at 0.0005, resulting in the occurence of 45000 temporal
iterations. Every 5 time iterations, the program selects new tip cells if some
requirements are met.
The activated tip cells must obey the following conditions to be chosen to have
that phenotype and for their activation to occur:
• The value of φ at the cell must be higher than 0.9;
• The value of T at the cell must be higher than Tc, the concentration of angio-
genic factor that allows the branching;
• The absolute value of the vector gradient of T , |∇T |, calculated in the point,
must be greater than Gm, the angiogenic factor gradient for branching;
• The cell is, finally, a tip cell if there is not any tip cell in a neighbourhood
defined by a distance of 4 times the cells radius, Rc.
The center of the new cell must be located further than a cell radius length
from the surface of the capillary.
Tc is a function of d, the oxygen diffusion area.
Tc is the upper limit for cell activation to occur. Extremelly high values of
Tc lead to no tip cell activation, since the value of the T for branching to occur
becomes unattainable. If, in the opposite situation, Tc is too low there will be a low
value of T for activation of tip cells to occur, leading to a great amount of activated
cells. The attainment of the expression for Tc is performed finding the steady state
solution for T (continuous at a point a, which corresponds to the capillary wall),
solving the equations in Appendix A.
Due to the fact that obtaining a computational solution of a stationary solution
to the equation of T is a very slow process, in this simulation, an approximation
was made for the value of Tc, which was defined as a constant value of 0.055,
although the value produced by the resolution of the equations in Appendix A is
different.
The first condition guarantees that the tip cell is chosen from the cells that are
located inside the capillar, the second indicates the existence of angiogenic factor
in the vicinity of the cell which is responsible for triggering EC’s differentiation;
the third condition assures the existence of a gradient of T which allows the tip
cell to move and, the final condition, respects the notch signaling existing between
cells and defines that a new tip cell only acquires that phenotype if there is not any
tip cell immediately next to it, which represents a distance between the centers of
the two cells of 4Rc.
The first three conditions must be met at the center of the endothelial cell so
that it can be classified with that phenotype, and because of the notch signalling
pathway, the fourth and last condition must be obeyed since two neighboring cells
can not be both tip cells.
The gradient of angiogenic factor is calculated through the calculation of the
absolute value of the gradient vector. Each component of this vector in every
dimension is reached by the subtraction of the value of T (x + δx) and T (x − δx),
divided by twice the step, for the x case, according to the Taylor series. Appendix
E presents the deduction of this equation.
Following the same procedure that characterizes the biological systems, when-
ever the chemotactic signal is low, the endothelial cell becomes a stalk cell again;
this is, when T < Tc and |∇T | < Gm.
Every time the program ascertains the existence of cells fullfilling the four
referred conditions, the points satisfying them are positioned in the matrix
tipcellslocal. From all the cells which can constitute tip cells and that are in the
tipcellslocal matrix, one is randomly chosen and added to the matrix tipcellsglobal
of the program, where all the tip cells are saved.
The already chosen tip cells saved in the tipcellsglobal matrix, are moved
in every time unit. The new positions are determined by the cells’ velocity ν,
which changes between two contiguous time units since the velocity is directly
proportional to the gradient of T , which also changes in every time unit. The
gradient of T is now calculated as the mean of the local gradients of T in the
neighborhood defined by a sphere centered in the cell, with a radius equal to 2Rc.
The velocity of the tip cells is proportional to the gradient of T , as already
referred. The proportionality constant is χ, the chemotactic response of ECs
which defines the magnitude of the ECs’ movement triggered by the gradient of
angiogenic factors. The new position is obtained by adding the product of the
velocity and the time step to the previous position in all the three dimensions
of the system. The velocity of the tip cells is kept in a matrix with the same
name. Before the tip cells included in the tipcellsglobal are moved, the program
ascertains whether the values of T and ∇T of that tip cells are higher than cut-off.
If they are lower, the cell is no longer a tip, becomes a stalk cell and is removed
from the tipcellglobal matrix. The matrix with the velocities of the tip cells is also
updated.
The value of φ of the cells whose centers are located at a distance defined by Rc
from the tip cells (the centers of the tip cells) already included in the tipcellsglobal
matrix, are updated in every time unit using equation 3.6. In these circumstances,
T evolves according to equation 3.4 as the model considers that at the tip cell, the
angiogenic factors are not consumed, they only diffuse. For all the other points of
the system, the update of the values of T and φ is performed through equations
3.2 and 3.3.
In every 5000 time unit intervals, the program produces three files that allow
the attainment of a perspective of the time evolution of the important aspects
considered in the simulation:
• The ECs’ density that defines the tree-like vascular network with sprouts
emerging from a central capillar;
• The active and angiogenic factor producing hypoxic cells and, finally,
• The space distribution of the angiogenic factor T .
The next table presents the list of parameters used in the simulation, a small
description and their values.
Table 3.1: List of Parameters and their Descriptions and Values in Simulation
Parameter Description Value in Simulation
ifinal x dimension of the system 100
jfinal y dimension of the system 100
kfinal z dimension of the system 60
δx x step size 1
δy y step size 1
δz z step size 1
Rc Cells radius 4
χ Chemotactic response of the ECs 1000
D Diffusion constant 100
M Endothelial cell mobility 1
αT Angiogenic factor consumption rate 6.25
αP Endothelial cell proliferation rate 1
 Interface width 1
Tp Angiogenic factor concentration for highest proliferation 0.3
Tc Angiogenic factor concentration for branching 0.055
capillar radius Initial Radius of the capillar 5
d Oxygen diffusion length 10
Gm Angiogenic factor gradient for branching 0.01
Some of the parameters in the previous table are changed during the simula-
tion in order to compare their effects on the obtained results.
The following code’s flowchart schematically sumarizes the structure of the
computational program and its behaviour.
Figure 3.1: Code’s Flowchart.
Chapter 4
Simulation’s Results and
Discussion
4.1 Initial conditions
The program was executed from t = 0.0005, the time step chosen that satisfies the
equations of the model requirements for a viable simulation, to t = 22.5, which
corresponds to 45000 temporal iterations.
In the following figures, comparisons between the effects of different pa-
rameters are presented. The discussion of these effects on the time and space
evolutions of the system is also presented in this chapter.
In figure 4.1, the initial conditions for the parameter φ and the variable T are
presented, for a number of sources of 500 and 1000.
(a) (b)
Figure 4.1: (a) Initial conditions for φ and T , for N = 500 sources; (b) Initial condi-
tions for φ and T , for N = 1000 sources.
The red dots represent values of φ = 1, the initial capillar. The green crosses
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are the 500 and 1000 angiogenic factor sources, hypoxic cells, at t = 0, respectively.
4.2 Analysis of the effect of the number of ang. factor
sources on the system dynamics
Figure 4.2 shows the space distribution of the angiogenic factor sources 5000 and
45000 temporal iterations after the beginning of the simulation, for an initial value
of sources equal to 500.
(a) (b)
Figure 4.2
(a) angiogenic factor sources for t = 0.0005 (5000 iterations), for N = 500; (b) angio-
genic factor sources for t = 22.5 (45000 iterations), for N = 500.
At t = 0.0005, which corresponds to figure 4.2(a), some of the 500 angiogenic
factor sources have already been withdrawn due to the fact that that their initial
positions are in the oxygen diffusion area which, in these results, corresponds to
the area defined by the distance of d = 20, from the capillar. The same is valid for
the case of the existence of 1000 sources, represented in the figure 4.3.
(a) (b)
Figure 4.3: (a) Angiogenic factor sources for t = 0.0005 (5000 iterations), for N =
1000; (b) Angiogenic factor sources for t = 22.5 (45000 iterations), for N = 1000.
With the model simulation, some of these points disappear since, with vessel
sprouting resulting from the production and diffusion of T , the angiogenic factor
balance, at each time iteration, some sources will be at a distance less than d from
the nearby vessels, becoming, no longer, hypoxic cells.
45000 temporal iterations after, at t = 22.5, the distribution of angiogenic factor
sources is represented in figures 4.2(b) and 4.3(b), for initial values of sources of
500 and 1000, respectively.
Figures 4.2 and 4.3 were obtained for the following parameters:
• d = 20
• αP = 1.0
• χ = 1000
Every 5000 iterations, the program saves the positions of the hypoxic cells in a
file. The 9 files obtained were combined in a video that illustrates the evolution of
the sources with time. The files N500.gif and N1000.gif in the attached CD are
the videos representing the time evolution of the hypoxic cells for initial numbers
of 500 and 1000 hypoxic cells, respectively.
9 files with the time evolution of the parameter φ and of T are also obtained for
each case. The next paragraphs will compare the influence of a difference in the
initial numbers of hypoxic cells added to the system on its evolution.
The following figure shows the time evolution of the parameter φ for 5000,
25000, 35000 and 45000 iterations, for N = 500, d = 20, αP = 1.0 and χ = 1000.
(a) (b)
(c) (d)
Figure 4.4: Parameter φ for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations; for
N = 500. Lower values of angiogenic factor sources lead to less sprouting and less
proliferative vessels.
The following figure shows the time evolution of the parameter φ for 5000,
25000, 35000 and 45000 iterations, for N = 1000, d = 20, αP = 1.0 and χ = 1000.
(a) (b)
(c) (d)
Figure 4.5: Parameter φ for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations; for
N = 1000. Higher values of angiogenic factor sources lead to higher sprouting and
greater proliferative vessels.
From the previous images, we can observe that, a the number of hypoxic cells
higher consequently leads to an increase in the production of angiogenic factor
T . After 5000 iterations of the start of the simulation, there is no sprouting in
both cases and, after 25000 iterations, although in both cases sprouting occurs, the
interior part of the central vessel and its ramifications has already values between
1 and 1.5, forN = 1000, which is a sign of high proliferation of the vessels. The ECs’
proliferation, combined with the existence of a gradient of angiogenic factor, leads
to the occurence of sprouting of the vessels from the original capillar earlier and
with a higher magnitude. Figures 4.4(c) and 4.5(c) already show a proliferative
vessel in the case where N = 500, although, when compared to the case of figure
4.5(c), where N = 1000, more vessels are approaching the system’s boundaries.
Finally, in figures 4.4(d) and 4.5(d), it becomes clear that, for N = 1000, the vessels
have higher values of φ due to a higher proliferation and they are more frequent.
The following figure shows the time evolution of the points with φ > 0, points
where there is capillar, for 5000, 25000, 35000 and 45000 iterations, for N = 500,
d = 20, αP = 1.0 and χ = 1000.
(a) (b)
(c) (d)
Figure 4.6: Time evolution of the points with φ > 0, points where there is capillar
for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for N = 500. Lower values of
angiogenic factor sources lead to less sprouting.
The following figure shows the time evolution of the points with φ > 0, points
where there is capillar, for 5000, 25000, 35000 and 45000 iterations, for N = 1000,
d = 20, αP = 1.0 and χ = 1000.
(a) (b)
(c) (d)
Figure 4.7: Time evolution of the points with φ > 0, points where there is capillar
for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for N = 1000. Higher values of
angiogenic factor sources lead to higher sprouting.
The previous images are also dedicated to the analysis of the parameter φ
but only for the points with values higher than 0 are ilustrated. These points
represent the tree of sprouts that emerge from the initial capillar. In these figures,
the previous conclusions become clearer.
The following images also analyse the situation described but in what concerns
the variable T .
The following figure shows the time evolution of the variable T for 5000, 25000,
35000 and 45000 iterations, for N = 500, d = 20, αP = 1.0 and χ = 1000.
(a) (b)
(c) (d)
Figure 4.8: Parameter T for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations; for
N = 500. Lower values of angiogenic factor sources lead to lower angiogenic factor
consumption.
The following figure shows the time evolution of the variable T for 5000, 25000,
35000 and 45000 iterations, for N = 1000, d = 20, αP = 1.0 and χ = 1000.
(a) (b)
(c) (d)
Figure 4.9: Parameter T for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for
N = 1000. Higher values of angiogenic factor sources lead to higher angiogenic
factor consumption.
The previous images show that, as expected, for N = 500, at 5000 iterations,
the values of T of the system are lower than those for N = 1000. The color scale
shows the prevalence of the red color which represents values from 5.5 to 6.5,
rather than the orange in the N = 1000 figure, where the values are between 0.7
and 0.9. In both figures, the yellow dots represent the angiogenic factor sources,
hypoxic cells, which have values of T equal to 1. In both figures 4.8(a) and 4.9(a)
there is no spouting occuring yet since the lower values of T , which occur in the
central region of the figure and represent the initial vessel, are confined to this
area. The vessel has values between 0 and 0.4, the lowest in both graphs, since
the angiogenic factor in this region, unlike in the rest of the 3D system, not only
diffuses according to equation 3.2, but is also consumed.
20000 time iterations after, the occurence of sprouting in both graphs is clear
due to the extension of the lower values to the ramifications already seen in the
previous figures for the evolution of the φ parameter. Nevertheless, outside the
capillar tree, we see that the values of T are higher for N = 1000 than for N = 500,
as expected. The same pattern is observed for 35000 iterations.
Figures 4.8(d) and 4.9(d) already show a considerable part of the 3D system
with low values of T due to the sprouting that extends these values from the
center of the system to its boundaries being, again, the values of T for N = 1000
higher than those for N=500, although the spouting effect on T is not so clear than
in figures 4.7 and 4.6.
The files N500phi.gif , N500T.gif , N1000phi.gif and N1000T.gif show the
videos of the time evolution of the values of φ and T , for N = 500 and N = 1000,
respectively, from 5000 to 45000 temporal iterations.
4.3 Analysis of the effect of the proliferation rate αP on the
system dynamics
Two values of αP , the ECs’ proliferation, are used in the simulations, 1.0 and 2.0.
We expect that, for αP = 1.0, since the EC’s proliferation is lower, a lower
number of ramifications and thiner vessels occur comparatively to αP = 2.0.
The parameters used in the following figures were:
• d = 20
• N = 1000
• χ = 1000
The following images show the φ distributions in the 3D system for αP = 1.0
and αP = 2.0.
(a) (b)
(c) (d)
Figure 4.10: Parameter φ for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for
αP = 1.0. Lower values of proliferation rate lead to thinner, less proliferative and
ramified vessels.
(a) (b)
(c) (d)
Figure 4.11: Parameter φ for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for
αP = 2.0. Higher values of proliferation rate lead to thicker, more proliferative and
ramified vessels.
The files alphaT1.0phi.gif and alphaT2.0phi.gif in the attached CD are the
videos of the time evolution of the values of φ for αP = 1.0 and αP = 2.0, respec-
tively, from 5000 to 45000 temporal iterations.
Figures 4.10 and 4.11 show the referred expected aspects. A higher prolifera-
tion rate leads to higher values of φ which are represented by the prevalence of
the yellow color inside the vessels when αP = 2.0, higher number of ramifications
and thicker vessels.
In this analysis, the tree figures are not shown since the referred aspects are
more evident in the previous figures.
In what concerns the evolution of T , it is expected that, since a higher prolifer-
ation leads to an increase in the number and thickness of the sprouts, the values
of T will evolve resulting in lower values of this parameter since the angiogenic
factor represented by the parameter T is more consumed by the generated vessels.
The following figures show the evolution of the parameter T for both the
considered αP values and for 5000, 25000, 35000 and 45000 temporal iterations.
(a) (b)
(c) (d)
Figure 4.12: Parameter T for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for
αP = 1.0. Lower values of proliferation rate lead to a distribution of the parameter
T with higher values comparing to a higher value of proliferation rate.
(a) (b)
(c) (d)
Figure 4.13: Parameter T for (a) 5000; (b) 25000; (c) 35000; (d) 45000 iterations, for
αP = 2.0. Higher values of proliferation rate lead to a distribution of the parameter
T with lower values comparing to a lower value of proliferation rate.
The values of T in the scales of the previous figures are consistent with what
was expected.
In particular, the fast growth of the vascular tree for α = 2.0 leads to a faster
depletion of T , dropping to almost zero in 35000 iterations.
The files alphaT1.0t.gif and alphaT2.0t.gif in the attached CD are the videos of
the time evolution of the values of T for αP = 1.0 and αP = 2.0, respectively, from
5000 to 45000 temporal iterations.
4.4 Analysis of the effect of the chemotactic response χ on
the system dynamics
In this stage of the work, we decided to use a value of Tc = 0.2, in order to decrease
the number of ramifications and being easier to compare the results. This value is
still lower than the maximum value for Tc calculated in Appendix A.
Using this value of Tc and in order to compare and analyse the effect of the
chemotactic response χ on the system dynamics, two values of the chemotactic
response were used in the simulation. The values χ = 500 and χ = 1000 were used.
This parameter influences the magnitude of the vessels response to the
existence of angiogenic factor. It is the parameter which influences the velocity at
which tip cells move along the system. Since χ is proportional to the velocity of tip
cells, higher values of χ will lead to thinner and more ramified vessels. The reason
for being thinner lies in the fact that, as the velocity is higher, every cell stays
a smaller period of time in every point of the system, being unable to proliferate
more. This fact leads, obviously, to the occurence of thinner vessels. The increase
in the number of ramifications may be explained by the fact that, being thinner,
more empty spaces are left between ramifications that allow the emergence of
new tip cells and, consequently, new vessels.
The parameters used in the following figures were:
• d = 20
• αP = 1.0
• N = 1000
The following figures show the evolution of the parameter φ for both the
considered χ values and for 5000, 10000, 15000, 20000, 25000 and 30000 temporal
iterations.
(a) (b) (c)
(d) (e) (f)
Figure 4.14: Parameter φ for (a) 5000; (b) 10000; (c) 15000; (d) 20000; (e) 25000; (f)
30000 iterations, for χ = 500. Lower values of chemotactic response lead to thicker
and less ramified vessels.
In figures 4.14 and 4.15, it appears that for χ = 1000 the vessels are thinner
and more ramified than for χ = 500.
In order to better verify this aspect, the tree-like figures were obtained.
Figures 4.16 and 4.17 show the points with φ > 0, points where there is capillar
for both the considered χ values and for 5000, 10000, 15000, 20000, 25000 and 30000
temporal iterations.
(a) (b) (c)
(d) (e) (f)
Figure 4.15: Parameter φ for (a) 5000; (b) 10000; (c) 15000; (d) 20000; (e) 25000;
(f) 30000 iterations, for χ = 1000. Higher values of chemotactic response lead to
thinner and more ramified vessels.
The number of ramifications becomes clearer in figures 4.16 and 4.17. Because
there are many vessels in these two structures, in this 3D representations, though
we are left with the impression of thinner vessels, we cannot be certain. However,
because of the lower value of χ, the network for χ = 500 grows slower than for
χ = 1000, and if it was left to evolve for a longer time (to reach the size of the
χ = 1000 network at 30000 iterations), we expect the vessels to become much
thicker. In any case, the introduction of a function in the simulation that would
allow the achievement of a numerical analysis of the width of the vessels and of
the number of branches as well, would be very useful. This is one of the aspects
which would be important to introduce in the future in order to improve the
analysis of the obtained results.
The files chi500phi.gif , chi1000phi.gif , chi500phitree.gif , chi1000phitree.gif in
the attached CD are the videos of the time evolution of the values of φ for χ = 500
and χ = 1000, and the tree-like figures for both the χ values, respectively.
(a) (b) (c)
(d) (e) (f)
Figure 4.16: Time evolution of the points with φ > 0, points where there is capillar
for (a) 5000; (b) 10000; (c) 15000; (d) 20000; (e) 25000; (f) 30000 iterations, for χ = 500.
Lower values of chemotactic response lead to thicker and less ramified vessels.
Figures 4.18 and 4.19 show the time evolution of factor T for both χ values.
Trees with thicker vessels are expected to lead to a higher consumption of angio-
genic factor.
The angiogenic factor consumption is similar in the two cases studied since,
while the vessels with χ = 500 are expectedly thicker, the vessels with χ = 1000
are more ramified. These two aspects contribute to angiogenic factor consumption.
The files chi500t.gif and chi1000t.gif in the attached CD are the videos of the
time evolution of the values of T for χ = 500 and χ = 1000, respectively.
(a) (b) (c)
(d) (e) (f)
Figure 4.17: Time evolution of the points with φ > 0, points where there is capillar
for (a) 5000; (b) 10000; (c) 15000; (d) 20000; (e) 25000; (f) 30000 iterations; for χ = 1000.
Higher values of chemotactic response lead to thinner and more ramified vessels.
(a) (b) (c)
(d) (e) (f)
Figure 4.18: Parameter T , for (a) 5000; (b) 10000; (c) 15000; (d) 20000; (e) 25000; (f)
30000 iterations; for χ = 500.
(a) (b) (c)
(d) (e) (f)
Figure 4.19: Parameter T , for (a) 5000; (b) 10000; (c) 15000; (d) 20000; (e) 25000; (f)
30000 iterations; for χ = 1000.
Chapter 5
Conclusions and Future Work
Angiogenesis is a complex process that involves a large amount of proteins and
factors which must be thoroughly controled, allowing an adequate stimulus to
occur. However, this not always happens and in the last 20 years, angiogenesis
has been seen by investigators of various fields as a way to obtain promising
therapeutics that would improve the life of at least 1 bilion of people worldwide.
The central goal of this project was achieved with success. The model is now
completely implemented in 3D.
The program was tested for various different parameters. The number of
hypoxic cells introduced in the system, the chemotactic response of tip cells
and the proliferation rate of stalk cells were changed to different values and
the results obtained analysed. From this analysis, it became clear that the
implementation of the model was successful since all of the results agree with the
aspects theoretically and mathematically expected.
The fact of being a three-dimensional simulation is an inovative aspect of this
simulation since there are very few models of angiogenesis in 3D, leading the
study and results to more realistic versions of the process of angiogenesis.
Nevertheless, it would be interesting to include in the model and in the
simulation some other aspects considered in other models studied in order to
improve the results and obtain a better approximation to the reality.
One of these aspects is the differentiation of the various VEGF isoforms in
the equation that modulates the balance between angiogenic factors, and also
consider their heparin-binding properties which would affect their velocity and
travelled distance during their diffusion.
Some other aspects could be included in the model such as the hapto-
taxis stimulus, the angipoietins regulation action and the HIF stimulus. The
EM could also be considered a viscoelastic fluid and not only the diffusion medium.
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One of the future steps of this project is to parallelize the program, using
the cluster milipeia. The classes of Parallel Computation were an essential
background for the achievement of this future goal.
Once the program includes the most important aspects of angiogenesis and is
fully optimized, its application to pathological conditions would be a very interest-
ing step. Cancer and Diabetic Retinopathy are two disorders which, due to the
incidence in the world’s population, would be important to simulate.
Appendix A
Deduction of the expressions of Tc
and αT
The expression for Tc, the angiogenic factor concentration for branching, is
estimated finding the steady state solution for T in 2D, continuous at r = a, the
radius of the initial capillary, and considering that T = 1 at r = d + a, the nearest
position of the sources of angiogenic factor in the tissue.
Simplifying equation 3.1 for a very sharp interface, the following equations are
obtained in 2D:
∂tT = D∇
2T, x ≥ 0 (A.1)
and
∂tT = D∇
2T − αTT, x < 0. (A.2)
In polar coordinates, the previous equations become:
D∇2T = 0⇔
D
r
∂r(r∂rT ) = 0⇔ r∂rT = c1 ⇔ (A.3)
⇔ ∂rT =
c1
r
⇔ T = c1 ln(r) + c2
and
D∇2T − αTT = 0⇔
D
r
∂r(r∂rT )− αTT = 0⇔ (A.4)
⇔ ∂rT + r∂
2
rT −
αT r
D
T = 0⇔ r2∂2rT + r∂rT −
αT
D
r2T = 0.
Substituing the expression
√
(αT
D
)r by x, we have:
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x2∂2xT + x∂xT − x
2T = 0. (A.5)
The solution to the previous equation using the bessel functions I0 and K0 is:
T = c3I0(x) + c4K0(x) (A.6)
and since the shape of the curve that defines the evolution of T in the space is
an exponential with a positive exponent, the second term of the right side of the
previous equation is ignored. The final expression for T is the following:
T = c3I0(
r
Rc
). (A.7)
Three conditions are used to find the three constants c1, c2 and c3 of the equa-
tions A.3 and A.7:
• The value of T in the nearest source to the capillar is 1; T (a+ d) = 1
• T must be continuous at a
• The derivative of T must be continuous at a
The three conditions referred can be transformed in an equations system, as
follows:


c1 ln(a+ d) + c2 = 1
c1 ln(a) + c2 = c3I0(
a
Rc
)
c1
a
= c3
I
−1(
a
Rc
)
Rc
⇔


c1 =
xI
−1(x)
I0(x)+xI−1(x) ln(
a+d
a
)
c2 =
I0(x)−xI−1(x) ln(a)
I0(x)+xI−1(x) ln(
a+d
a
)
c3 =
1
I0(x)+xI−1(x) ln(
a+d
a
)
where x = a
Rc
At a distance of Rc inside the capillar, the value of T that allows the occurence
of branching is Tc, which can be calculated by finding the value of T (a−Rc).
T (a− Rc) =
I0(
a−Rc
Rc
)
I0(x) + xI−1 ln(
a+d
a
)
⇔ T (a− Rc) =
I0(
a
Rc
− 1)
I0(
a
Rc
) + a
Rc
I−1(
a
Rc
) ln(1 + d
a
)
(A.8)
The value of a is the radius of the capillar (cell radius=5, in this simulation).
For the values in the simulation we obtain that T (a− Rc) ≈ 0.34, which means
that the parameter Tc should be smaller than 0.34 for branching to occur.
Appendix B
Deduction of the Equation 3.1 [1, 2, 3]
Equation 3.1 describes the evolution of the factor T , the balance between the
angiogenic factors intervening in the process of angiogenesis.
The continuity equation states that a change in the density in any part of a
system is due to inflow or outflow of material into or out of the system and its
expression is the following:
∂T
∂t
+∇ ·~j = 0, (B.1)
where ~j is the flux of the diffusing material.
Considering the expression of the first Fick’s law in three dimensions:
~J = −D∇T (~r, t) (B.2)
and replacing the flux ~J in the continuity equation, the equation becomes as fol-
lows:
∂T
∂t
+∇ · (−D∇T (~r, t)) = 0. (B.3)
Since D, the diffusion constant is not a function but a constant value, D may be
withdrawn out of the brackets and the divergence of the previous equation will be
performed on the gradient of T , which results in the laplacian of T , as expressed
by the following equation:
∂T
∂t
−D∇2T = 0↔
∂T
∂t
= D∇2T. (B.4)
Equation 3.2 is completed, adding to equation A.4 the term of consumption of
angiogenic factors.
In this term, appears the consumption rate αT , the values of T and φ and the
Heaviside function. Because of this function, the consumption term is only present
inside the capillar where the angiogenic factors are consumed by the ECs that
compose it and, on the outside of the capillar, the angiogenic factors only diffuse
from its production sites, the randomly distributed hypoxic cells.
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Appendix C
Deduction of the Equation 3.2 [1, 2, 3]
In what concerns equation 3.2, φ represents an order parameter which is dis-
tributed in the system. To this distribution, a free energy is associated given
by F [φ], with F the free energy of the system, a functional depending on φ, the
phase-field variable of the model.
In this model, the authors consider the existence of two phases of φ in the sys-
tem, one representing the capillar’s interior and the other its exterior, separated
by an interface. Inside the capillar, φ = 1 and outside φ = −1 and, consequently,
the capillar wall is defined by φ = 0.
The Ginzburg-Landau free energy functional is given by:
F [φ] =
∫ [
f(φ)−

2
(∇φ)2
]
dr, (C.1)
where f(φ) is a function of φ defined by:
f(φ) = −
φ2
2
+
φ4
4
. (C.2)
The values assumed by the function f that minimize the free energy will be the
minimal values of f . Solving df
dφ
= 0 gives:
φ = −1 ∨ φ = 1 ∨ φ = 0. (C.3)
The two minimal values φ = −1 and φ = 1 correspond to the two equilibrium
stages, the two phases of φ in the system. φ = 0 corresponds to the place repre-
sented by the interface and the term 
2
(∇φ)2 arises as a ’penalty’ term from the
extra energetic cost associated with the transition region between the two phases.
 represents the interface width of the capillaries. When the order parameter φ is
not conserved, an appropriate equation for the time evolution of the field φ is:
∂φ
∂t
= −
δF
δφ
, (C.4)
where the minus sign is due to the system evolution towards the minimization of
the free energy.
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For the conserved case, the quotient ∂φ
∂t
is written as:
∂φ
∂t
+∇ ·~j = 0, (C.5)
which is the continuity equation, where ∇ · ~j is the divergence of ~j, and ~j is given
by:
~j = M(−∇µ) (C.6)
and µ is the chemical potential given by:
µ =
δF [φ]
δφ
. (C.7)
The time evolution of the order parameter φ, depends also on a constant M
which represents the ECs’ mobility; consequently, we have:
∂φ
∂t
= M (−∇2
δF
δφ
). (C.8)
From the definition of functional derivative, we have:
F [φ+ δφ]− F [φ] =
∫
δF
δφ
δφ dr. (C.9)
To determine the expression of δF
δφ
, the expression of F [φ + δφ] − F [φ] must be
determined before.
F [φ+ δφ] is given by:
F [φ+ δφ] =
∫ [
−
(φ+ δφ)2
2
+
(φ+ δφ)4
4
+

2
[∇φ+∇δφ]2
]
dr. (C.10)
Solving the previous equation, we obtain:
F [φ+ δφ] =
∫ [
−
φ2 + 2φδφ+ δφ2
2
+
φ4 + δφ4 + 2φ2δφ2 + 4φ3δφ+ 4φ2δφ2 + 4φδφ3
4
+
(C.11)

2
[(∇φ)2 + 2∇φ∇δφ+ (∇δφ)2]
]
dr,
which can be simplified to the following expression as the powers of δφ with
exponent higher than 1 are negligible:
F [φ+ δφ] =
∫ [
−
φ2 + 2φδφ
2
+
φ4 + 4φ3δφ
4
+

2
[(∇φ)2 + 2∇φ∇δφ]
]
dr (C.12)
. (C.13)
Since F [φ] is given by:
F [φ] =
∫ [
−
φ2
2
+
φ4
4
+

2
(∇φ)2
]
dr, (C.14)
the expression of F [φ+ δφ]− F [φ] is given by:
F [φ+ δφ]− F [φ] =
∫ [
− φδφ+ φ3δφ+ ∇φ∇δφ
]
dr. (C.15)
In order to find an expression putting δφ in evidence, the term ∇φ∇δφ must
be integrated once by parts. After a bit of algebra, the obtained expression to
F [φ+ δφ]− F [φ] is the following:
F [φ+ δφ]− F [φ] =
∫ [
(−φ + φ3 − ∇2φ) δ φ
]
dr, (C.16)
resulting in
∂φ
∂t
= M (−
δF
δφ
) = −M(−φ + φ3 − ∇2φ). (C.17)
From the continuity equation, we take:
∂φ
∂t
= −∇ ·~j, (C.18)
where replacing j and µ by the expressions C.6 and C.7, gives:
∂φ
∂t
= M∇2
δF
δφ
= M∇2(−φ + φ3 − ∇2φ). (C.19)
The right side of equation C.19 is the first term of the second equation of the
model and determines the dynamics of the interface between the capillar and what
surrounds it. Equation 3.3 is completed by the endothelial cell proliferation term
which is composed by the values of the function φ, the proliferation rate αp(T )
and the Heaviside function. This function takes the value 1 inside the capillar
and 0 outside which leads to the conclusion that outside the capillar, the equation
that represents the time evolution of the phase-field parameter φ becomes equal to
equation C.19 and, only inside the capillar, the endothelial cell proliferation term
is considered.
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Appendix D
Deduction of the Equation 3.6 [1]
The material produced by the region inside the tip cells, per unit time, is equal
to the proliferation rate αp(T ) multiplied by the volume of the tip cell,
4
3
piR3c . In
every time unit, the cell moves with a velocity ν and travels the corresponding
to its area, piR2c |ν|. The resulting arterial density φc (3.6) is obtained dividing the
produced material by the swept area.
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Appendix E
Deduction of the expressions of
the gradient and laplacian of T
According to the Taylor series:
T (x+ δx, y, z) = T (x, y, z) + δxT ′(x, y, z) +O(δx2) (E.1)
and
T (x− δx, y, z) = T (x, y, z)− δxT ′(x, y, z) +O(δx2). (E.2)
Subtracting the two previous equations gives:
T (x+ δx, y, z)− T (x− δx, y, z) = 2δxT ′(x, y, z) +O(δx2), (E.3)
which gives:
T ′(x, y, z) =
T (x+ δx, y, z)− T (x− δx, y, z)
2δx
+O(δx2). (E.4)
The previous expression gives the equation for the gradient of T of the x
component.
The gradient of a vector T which is composed by three coordinates is conse-
quently given by:
∇T (x, y, z) =
T (x+ δx, y, z)− T (x− δx, y, z)
2δx
+ (E.5)
T (x, y + δy, z)− T (x, y − δy, z)
2δy
+
T (x, y, z + δz)− T (x, y, z − δz)
2δz
.
In order to deduce the laplacian expression from the Taylor series, we have:
T (x+ δx, y, z) = T (x, y, z) + δxT ′(x, y, z) +
δx2T ′′(x, y, z)
2!
+O(δx3) (E.6)
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and
T (x− δx, y, z) = T (x, y, z)− δxT ′(x, y, z) +
δx2T ′′(x, y, z)
2!
+O(δx3). (E.7)
Adding the two previous equations, we have:
T (x+ δx, y, z) + T (x− δx, y, z) = 2T (x, y, z) + 2
δx2T ′′(x, y, z)
2!
+O(δx3), (E.8)
which results in:
T ′′(x, y, z) =
T (x+ δx, y, z) + T (x− δx, y, z)− 2T (x, y, z)
δx2
+O(δx3), (E.9)
the equation for the laplacian of T of the x component.
The laplacian of a vector T for a three-dimensional system is:
∇2T (x, y, z) =
T (x+ δx, y, z) + T (x− δx, y, z)− 2T (x, y, z)
δx2
+ (E.10)
T (x, y + δy, z) + T (x, y − δy, z)− 2T (x, y, z)
δy2
+
T (x, y, z + δz) + T (x, y, z − δz)− 2T (x, y, z)
δz2
.
Appendix F
Computational Model
Program cond_init_phi.f90
MODULE cond_init_phi
USE global
IMPLICIT NONE
PRIVATE
PUBLIC :: phi1
CONTAINS
SUBROUTINE phi1(a1)
REAL, DIMENSION(ifinal,jfinal,kfinal) :: a1
INTEGER :: i, j, k
open(1,file=’1.out’,action=’write’)
DO i=1,ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (sqrt(((i-centroi)*1.0)**2+((j-centroj)*1.0)**2)<raio) THEN
phi(i,j,k)=1.0
write(1,*) i,j,k
ELSE
phi(i,j,k)=-1.0
END IF
END DO
END DO
END DO
CLOSE(UNIT=1)
END SUBROUTINE phi1
END MODULE cond_init_phi
Program cond_init_t.f90
MODULE cond_init_t
USE global
USE module_d_numpontos_factor
IMPLICIT NONE
PRIVATE
PUBLIC :: t1
CONTAINS
SUBROUTINE t1(b1,numpontosfinal)
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REAL, DIMENSION(ifinal,jfinal,kfinal) :: b1
REAL :: a,b,c, dist, r, tfinal, TT, RR,Tc,d,factor
INTEGER :: afinal, bfinal, cfinal,h, i, j, k,npn, numpontosfinal,numpontos
CALL d_numpontos_factor(numpontos,factor)
open(2,file=’2.out’,action=’write’)
t(:,:,:)=0.0
h=1
npn=0
DO WHILE (h<=(numpontos+1))
CALL RANDOM_NUMBER(a)
CALL RANDOM_NUMBER(b)
CALL RANDOM_NUMBER(c)
afinal=a*(ifinal-1)+1
bfinal=b*(jfinal-1)+1
cfinal=c*(kfinal-1)+1
t(afinal,bfinal,cfinal)=1.0
h=h+1
IF (sqrt(((afinal-centroi)*1.0)**2+((bfinal-centroj)*1.0)**2)<(raio+d)) THEN
t(afinal,bfinal,cfinal)=0.0
npn=npn+1
END IF
END DO
numpontosfinal=numpontos-npn
DO i=1,ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (t(i,j,k)==1.0) THEN
WRITE(2,*) i,j,k
END IF
END DO
END DO
END DO
CLOSE(UNIT=2)
CLOSE(UNIT=9)
END SUBROUTINE t1
END MODULE cond_init_t
File d.txt
20.0
1000
0.9
Program global.f90
MODULE global
IMPLICIT NONE
SAVE
INTEGER, PARAMETER :: kfinal=60, ifinal=100, jfinal=100, centroi=50, centroj=50
REAL, DIMENSION(ifinal,jfinal,kfinal) :: phi,t
REAL, PARAMETER :: delta_t=0.0005
REAL, PARAMETER :: raio=5.0
INTEGER, PARAMETER :: delta_x=1, delta_y=1, delta_z=1
INTEGER, PARAMETER :: Rc=4, chi=1000
REAL, PARAMETER :: pi = 3.1415927
REAL :: Vx,Vy,Vz,Rx,Ry,Rz,Gx,Gy,Gz,Tc,d
REAL, PARAMETER :: Gm=0.01
DOUBLE PRECISION, DIMENSION (500,3) :: tipcellsglobal
DOUBLE PRECISION, DIMENSION (500,3) :: velocity
INTEGER :: l
COMMON tipcellsglobal, velocity, l, d, Tc
END MODULE global
Program global2.f90
MODULE global2
IMPLICIT NONE
PRIVATE
PUBLIC :: fontes
CONTAINS
SUBROUTINE fontes(numpontosfinall,a)
INTEGER :: x,y,z,i,numpontosfinall
INTEGER, DIMENSION(numpontosfinall,3) :: a
OPEN(unit=2,file=’2.out’,action=’read’)
DO i=1,numpontosfinall
READ (2,*) x,y,z
a(i,:)=(/x,y,z/)
END DO
END SUBROUTINE fontes
END MODULE global2
Program grad.f90
MODULE grad
USE global
IMPLICIT NONE
CONTAINS
SUBROUTINE gradiente(nova_t,i,j,k,Gx,Gy,Gz)
REAL :: Gx,Gy,Gz
REAL, DIMENSION(:,:,:) :: nova_t
INTEGER :: i,j,k
Gx=((nova_t(mod(i+delta_x-1+ifinal,ifinal)+1,mod(j-1+jfinal,jfinal)+1,mod(k-1+kfinal,kfinal)+1))- &
(nova_t(mod(i-delta_x-1+ifinal,ifinal)+1,mod(j-1+jfinal,jfinal)+1,mod(k-1+kfinal,kfinal)+1)))/2
Gy=((nova_t(mod(i-1+ifinal,ifinal)+1,mod(j+delta_y-1+jfinal,jfinal)+1,mod(k-1+kfinal,kfinal)+1))- &
(nova_t(mod(i-1+ifinal,ifinal)+1,mod(j-delta_y-1+jfinal,jfinal)+1,mod(k-1+kfinal,kfinal)+1)))/2
Gz=((nova_t(mod(i-1+ifinal,ifinal)+1,mod(j-1+jfinal,jfinal)+1,mod(k+delta_z-1+kfinal,kfinal)+1))- &
(nova_t(mod(i-1+ifinal,ifinal)+1,mod(j-1+jfinal,jfinal)+1,mod(k-delta_z-1+kfinal,kfinal)+1)))/2
END SUBROUTINE gradiente
END MODULE grad
Program grad2.f90
MODULE grad2
USE global
IMPLICIT NONE
CONTAINS
SUBROUTINE gradiente2(nova_t,i,j,k,Gx,Gy,Gz)
REAL, DIMENSION(:,:,:) :: nova_t
INTEGER :: n
INTEGER :: i,j,k,x,y,z
REAL :: Gx,Gy,Gz
Gx=0
Gy=0
Gz=0
n=0
x=-2*Rc
DO WHILE (x<=2*Rc)
y=-2*Rc
DO WHILE (y<=2*Rc)
z=-2*Rc
DO WHILE (z<=2*Rc)
IF ((x**2+y**2+z**2) .lt. ((2*Rc)**2)) THEN
Gx=Gx+((nova_t(mod(i+x+delta_x-1+ifinal,ifinal)+1,mod(j+y-1+jfinal,jfinal)+1,mod(k+z-1+kfinal,kfinal)+1))- &
(nova_t(mod(i+x-delta_x-1+ifinal,ifinal)+1,mod(j+y-1+jfinal,jfinal)+1,mod(k+z-1+kfinal,kfinal)+1)))/2
Gy=Gy+((nova_t(mod(i+x-1+ifinal,ifinal)+1,mod(j+y+delta_y-1+jfinal,jfinal)+1,mod(k+z-1+kfinal,kfinal)+1))- &
(nova_t(mod(i+x-1+ifinal,ifinal)+1,mod(j+y-delta_y-1+jfinal,jfinal)+1,mod(k+z-1+kfinal,kfinal)+1)))/2
Gz=Gz+((nova_t(mod(i+x-1+ifinal,ifinal)+1,mod(j+y-1+jfinal,jfinal)+1,mod(k+z+delta_z-1+kfinal,kfinal)+1))- &
(nova_t(mod(i+x-1+ifinal,ifinal)+1,mod(j+y-1+jfinal,jfinal)+1,mod(k+z-delta_z-1+kfinal,kfinal)+1)))/2
n=n+1
END IF
z=z+1
END DO
y=y+1
END DO
x=x+1
END DO
Gx=Gx/n
Gy=Gy/n
Gz=Gz/n
END SUBROUTINE gradiente2
END MODULE grad2
Program laplacian.f90
MODULE laplacian
USE global
CONTAINS
SUBROUTINE laplaci(a,laplaciano)
IMPLICIT NONE
REAL, DIMENSION(:,:,:) :: a
REAL, DIMENSION(:,:,:) :: laplaciano
INTEGER :: x,y,z
DO x=1,ifinal
DO y=1,jfinal
DO z=1,kfinal
laplaciano(x,y,z)=((a(mod(x+delta_x-1+ifinal,ifinal)+1,y,z)+ &
a(mod(x-delta_x-1+ifinal,ifinal)+1,y,z)-2*a(mod(x-1+ifinal,ifinal)+1,y,z))/(delta_x**2))+ &
((a(x,mod(y+delta_y-1+jfinal,jfinal)+1,z)+a(x,mod(y-delta_y-1+jfinal,jfinal)+1,z)- &
2*a(x,y,z))/(delta_y**2))+((a(x,y,mod(z+delta_z-1+kfinal,kfinal)+1)+ &
a(x,y,mod(z-delta_z-1+kfinal,kfinal)+1)-2*a(x,y,z))/(delta_z**2))
END DO
END DO
END DO
END SUBROUTINE laplaci
END MODULE laplacian
Program module_d_numpontos_factor.f90
MODULE module_d_numpontos_factor
USE global
IMPLICIT NONE
CONTAINS
SUBROUTINE d_numpontos_factor(numpontos,factor)
INTEGER :: numpontoss,numpontos
REAL :: dd,factorr,factor
open(9,file=’d.txt’,action=’read’)
READ (9,*) dd, numpontoss, factorr
d=dd
numpontos=numpontoss
factor=factorr
Tc=factor/((exp(1.0))*(1.0+(d/Rc)))
Tc=0.055
END SUBROUTINE d_numpontos_factor
END MODULE module_d_numpontos_factor
Program out_writer_fontes.f90
MODULE out_writer_fontes
IMPLICIT NONE
PRIVATE
PUBLIC :: output_writer_fontes
CONTAINS
SUBROUTINE output_writer_fontes(nova_t,ifinal,jfinal,kfinal,file_name)
INTEGER, INTENT(IN) :: kfinal,ifinal, jfinal
REAL, DIMENSION(ifinal,jfinal,kfinal) :: nova_t
CHARACTER(LEN=*), OPTIONAL :: file_name
INTEGER :: i,j,k
CHARACTER(LEN=3) :: a
IF (present(file_name)) THEN
OPEN(UNIT=1, FILE=’Fontes/’//file_name//’.txt’, ACTION=’write’)
ELSE
OPEN(UNIT=2, FILE=’files2.txt’, ACTION=’read’)
READ(UNIT=2, FMT=*) a
OPEN(UNIT=1, FILE=’Fontes/’//trim(a)//’.txt’, ACTION=’write’)
END IF
DO i=1, ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (nova_t(i,j,k) .eq. 1.0) THEN
WRITE(1,*) i, j, k
END IF
END DO
END DO
WRITE(1,*) ’’
END DO
CLOSE(UNIT=1)
END SUBROUTINE output_writer_fontes
END MODULE out_writer_fontes
Program out_writer_phi.f90
MODULE out_writer_phi
IMPLICIT NONE
PRIVATE
PUBLIC :: output_writer_phi
CONTAINS
SUBROUTINE output_writer_phi(grelha_,ifinal,jfinal,kfinal,file_name)
INTEGER, INTENT(IN) :: kfinal,ifinal, jfinal
REAL, DIMENSION(ifinal,jfinal,kfinal) :: grelha_
CHARACTER(LEN=*), OPTIONAL :: file_name
INTEGER :: i,j,k
CHARACTER(LEN=3) :: a
IF (present(file_name)) THEN
OPEN(UNIT=1, FILE=’Phi/’//file_name//’.txt’, ACTION=’write’)
ELSE
OPEN(UNIT=2, FILE=’files1.txt’, ACTION=’read’)
READ(UNIT=2, FMT=*) a
OPEN(UNIT=1, FILE=’Phi/’//trim(a)//’.txt’, ACTION=’write’)
END IF
DO i=1, ifinal
DO j=1,jfinal
DO k=1,kfinal
WRITE(1,*) i, j, k, grelha_(i,j,k)
END DO
END DO
WRITE(1,*) ’’
END DO
CLOSE(UNIT=1)
END SUBROUTINE output_writer_phi
END MODULE out_writer_phi
Program out_writer_t.f90
MODULE out_writer_t
IMPLICIT NONE
PRIVATE
PUBLIC :: output_writer_t
CONTAINS
SUBROUTINE output_writer_t(grelha_,ifinal,jfinal,kfinal,file_name)
INTEGER, INTENT(IN) :: kfinal,ifinal, jfinal
REAL, DIMENSION(ifinal,jfinal,kfinal) :: grelha_
CHARACTER(LEN=*), OPTIONAL :: file_name
INTEGER :: i,j,k
CHARACTER(LEN=3) :: a
IF (present(file_name)) THEN
OPEN(UNIT=1, FILE=’T/’//file_name//’.txt’, ACTION=’write’)
ELSE
OPEN(UNIT=2, FILE=’files.txt’, ACTION=’read’)
READ(UNIT=2, FMT=*) a
OPEN(UNIT=1, FILE=’T/’//trim(a)//’.txt’, ACTION=’write’)
END IF
DO i=1, ifinal
DO j=1,jfinal
DO k=1,kfinal
WRITE(1,*) i, j, k, grelha_(i,j,k)
END DO
END DO
WRITE(1,*) ’’
END DO
CLOSE(UNIT=1)
END SUBROUTINE output_writer_t
END MODULE out_writer_t
Program projecto.f90
PROGRAM projecto
USE global
USE module_d_numpontos_factor
USE cond_init_phi
USE cond_init_t
USE global2
USE laplacian
USE update
USE tip
USE SubPosicao
USE out_writer_phi
USE out_writer_t
USE out_writer_fontes
IMPLICIT NONE
REAL, DIMENSION(ifinal,jfinal,kfinal) :: nova_t, nova_phi
INTEGER :: tempo, passos,i,j,k,numpontosfinall,x,y,z,q,di2,ii,a,iii,lig,f
INTEGER, DIMENSION(1000,3) :: fonte
INTEGER :: ligado(1000)
INTEGER :: istri
CHARACTER(LEN=4) :: stri
OPEN(3,FILE=’3.out’,ACTION=’write’)
OPEN(4,FILE=’4.out’,ACTION=’write’)
OPEN(5,FILE=’5.out’,ACTION=’write’)
OPEN(7,FILE=’7.out’,ACTION=’write’)
passos=int(500.0/delta_t)
CALL phi1(phi)
CALL t1(t,numpontosfinall)
CALL fontes(numpontosfinall,fonte)
nova_t(:,:,:)=t(:,:,:)
nova_phi(:,:,:)=phi(:,:,:)
DO di2=1,500
tipcellsglobal(di2,:)=(/0,0,0/)
velocity(di2,:)=(/0,0,0/)
END DO
l=0
DO lig=1,numpontosfinall
ligado(lig)=1
END DO
DO tempo=1,passos
CALL subupdate(nova_t,nova_phi,fonte,numpontosfinall,ligado)
IF ( MOD(tempo,5) == 0) then
CALL tipcell(nova_phi,nova_t)
END IF
iii=1
DO WHILE (iii<=l)
CALL posicao(iii,nova_t,Rx,Ry,Rz)
iii=iii+1
END DO
IF ( MOD(tempo,5000) == 0) then
WRITE(stri,’(i4)’) tempo/5000
istri=1
DO WHILE ( istri<=LEN(stri))
IF (stri(istri:istri) .EQ. ’ ’) THEN
stri(istri:istri)=’0’
END IF
istri=istri+1
END DO
CALL output_writer_phi(nova_phi,ifinal,jfinal,kfinal,stri)
CALL output_writer_t(nova_t,ifinal,jfinal,kfinal,stri)
CALL output_writer_fontes(nova_t,ifinal,jfinal,kfinal,stri)
END IF
END DO
DO x=1,ifinal
DO y=1,jfinal
DO z=1,kfinal
write(5,*) x, y, z, nova_t(x,y,z)
END DO
END DO
END DO
DO i=1,ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (nova_t(i,j,k)>Tc) THEN
WRITE (3,*) i,j,k
END IF
END DO
END DO
END DO
DO i=1,ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (nova_phi(i,j,k)>0.0) THEN
WRITE (4,*) i,j,k
END IF
END DO
END DO
END DO
DO i=1,ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (nova_t(i,j,k) .eq. 1.0) THEN
WRITE(7,*) i,j,k
END IF
END DO
END DO
END DO
CLOSE(UNIT=3)
CLOSE(UNIT=4)
OPEN(6,FILE=’6.out’,ACTION=’write’)
DO ii=1,l
WRITE(6,*) tipcellsglobal(ii,1), tipcellsglobal(ii,2), tipcellsglobal(ii,3)
END DO
CLOSE(UNIT=6)
CLOSE(UNIT=7)
END PROGRAM projecto
Program SubPosicao.f90
MODULE SubPosicao
USE global
USE grad2
IMPLICIT NONE
CONTAINS
SUBROUTINE posicao(iii,nova_t,Rx,Ry,Rz)
REAL, DIMENSION(:,:,:) :: nova_t
INTEGER :: iii,k
REAL :: Rx,Ry,Rz
Rx=tipcellsglobal(iii,1)
Ry=tipcellsglobal(iii,2)
Rz=tipcellsglobal(iii,3)
call gradiente2(nova_t,int(Rx),int(Ry),int(Rz),Gx,Gy,Gz)
IF (nova_t(int(Rx),int(Ry),int(Rz)) .gt. Tc .and. sqrt(Gx**2+Gy**2+Gz**2) .gt. Gm) THEN
Vx=chi*Gx
Vy=chi*Gy
Vz=chi*Gz
Rx=Rx+delta_t*Vx
Ry=Ry+delta_t*Vy
Rz=Rz+delta_t*Vz
tipcellsglobal(iii,1)=Rx
tipcellsglobal(iii,2)=Ry
tipcellsglobal(iii,3)=Rz
velocity(iii,1)=Vx
velocity(iii,2)=Vy
velocity(iii,3)=Vz
ELSE
DO k=iii,l-1
tipcellsglobal(k,1)=tipcellsglobal(k+1,1)
tipcellsglobal(k,2)=tipcellsglobal(k+1,2)
tipcellsglobal(k,3)=tipcellsglobal(k+1,3)
END DO
l=l-1
iii=iii-1
END IF
END SUBROUTINE posicao
END MODULE SubPosicao
Program tip.f90
MODULE tip
USE global
USE grad
USE module_d_numpontos_factor
IMPLICIT NONE
CONTAINS
SUBROUTINE tipcell(nova_phi,nova_t)
REAL, DIMENSION(ifinal,jfinal,kfinal) :: nova_phi, nova_t
INTEGER :: i,j,k,x,y,z,f,ptfinal,xmin,xmax,ymin,ymax,zmin,zmax,verifxx,verifyy,verifzz,iii,jjj,kkk,t,di1,it,b
INTEGER, DIMENSION (500,3) :: tipcellslocal
REAL :: pt
b=1
DO i=1,ifinal
DO j=1,jfinal
DO k=1,kfinal
IF (nova_phi(i,j,k)>0.9) THEN
IF (nova_t(i,j,k)>Tc) THEN
call gradiente(nova_t,i,j,k,Gx,Gy,Gz)
IF (sqrt(Gx**2+Gy**2+Gz**2) .gt. Gm) THEN
x=-Rc
f=0
DO WHILE (x<=Rc .and. f==0)
y=-Rc
DO WHILE (y<=Rc .and. f==0)
z=-Rc
DO WHILE (z<=Rc .and. f==0)
IF ((x**2+y**2+z**2) .lt. (Rc**2)) THEN
IF (nova_phi(mod(i+x-1+ifinal,ifinal)+1,mod(j+y-1+jfinal,jfinal)+1,mod(k+z-1+kfinal,kfinal)+1)<0.0) THEN
f=1
END IF
END IF
z=z+1
END DO
y=y+1
END DO
x=x+1
END DO
IF (f==0) THEN
xmin=mod(i-4*Rc-1+ifinal,ifinal)+1
xmax=mod(i+4*Rc-1+ifinal,ifinal)+1
ymin=mod(j-4*Rc-1+jfinal,jfinal)+1
ymax=mod(j+4*Rc-1+jfinal,jfinal)+1
zmin=mod(k-4*Rc-1+kfinal,kfinal)+1
zmax=mod(k+4*Rc-1+kfinal,kfinal)+1
it=1
DO WHILE (it<=l .and. f==0)
verifxx=0
verifyy=0
verifzz=0
iii=tipcellsglobal(it,1)
jjj=tipcellsglobal(it,2)
kkk=tipcellsglobal(it,3)
IF (xmax>xmin) THEN
IF (xmin<iii .and. iii<xmax) THEN
verifxx=1
END IF
END IF
IF (ymax>ymin) THEN
IF (ymin<jjj .and. jjj<ymax) THEN
verifyy=1
END IF
END IF
IF (zmax>zmin) THEN
IF (zmin<kkk .and. kkk<zmax) THEN
verifzz=1
END IF
END IF
IF (xmax<xmin) THEN
IF (iii<xmax .or. iii>xmin) THEN
verifxx=1
END IF
END IF
IF (ymax<ymin) THEN
IF (jjj<ymax .or. jjj>ymin) THEN
verifyy=1
END IF
END IF
IF (zmax<zmin) THEN
IF (kkk<zmax .or. kkk>zmin) THEN
verifzz=1
END IF
END IF
IF (verifxx .eq. 1) THEN
IF (verifyy .eq. 1) THEN
IF (verifzz .eq. 1) THEN
f=1
END IF
END IF
END IF
it=it+1
END DO
IF (f==0) THEN
tipcellslocal(b,1)=i
tipcellslocal(b,2)=j
tipcellslocal(b,3)=k
b=b+1
END IF
END IF
END IF
END IF
END IF
END DO
END DO
END DO
IF (b>1) THEN
l=l+1
CALL RANDOM_NUMBER(pt)
ptfinal=INT(pt*(b-1))+1
tipcellsglobal(l,:)=tipcellslocal(ptfinal,:)
END IF
END SUBROUTINE tipcell
END MODULE tip
Program update.f90
MODULE update
USE global
USE laplacian
IMPLICIT NONE
CONTAINS
SUBROUTINE subupdate(c1,c2,fonte,numpontosfinall,ligado)
REAL, DIMENSION(ifinal,jfinal,kfinal) :: c1,c2,c3
REAL, DIMENSION(ifinal,jfinal,kfinal) :: d1,d2
INTEGER ligado(500)
REAL, DIMENSION(ifinal,jfinal,kfinal) :: deltatt,deltaphi,deltaphi2, deltaphicubo
INTEGER, DIMENSION(numpontosfinall,3) :: fonte
INTEGER :: x,y,z,i,numpontosfinall,xmin,xmax,ymin,ymax,zmin,zmax,it,verifxx,verifyy,verifzz,iii,jjj,kkk,f,lig
INTEGER :: rx,ry,rz,ix,iy,iz
REAL :: alfat, Tp, alfaP, alfaP_T, D, M, E,dist,distnovo
D=100.0
alfat=6.25
M=1.0
E=1.0
Tp=0.3
alfaP=1.0
c3(:,:,:)=c2(:,:,:)*c2(:,:,:)*c2(:,:,:)
CALL laplaci(c1,deltatt)
CALL laplaci(c2,deltaphi)
CALL laplaci(c3,deltaphicubo)
CALL laplaci(deltaphi,deltaphi2)
d1(:,:,:)=c1(:,:,:)
d2(:,:,:)=c2(:,:,:)
DO x=1,ifinal
DO y=1,jfinal
DO z=1,kfinal
IF (d2(x,y,z)>0.9) THEN
DO lig=1,numpontosfinall
IF (ligado(lig) .eq. 1) THEN
dist=(ifinal*ifinal)*1.0
DO ix=-1,1
DO iy=-1,1
DO iz=-1,1
rx=fonte(lig,1)+ix*ifinal
ry=fonte(lig,2)+iy*jfinal
rz=fonte(lig,3)+iz*kfinal
distnovo=real((x-rx)*(x-rx)+(y-ry)*(y-ry)+(z-rz)*(z-rz))
IF (distnovo .lt. dist) THEN
dist=distnovo
END IF
END DO
END DO
END DO
IF (dist .lt. d) THEN
ligado(lig)=0
END IF
END IF
END DO
END IF
IF (d1(x,y,z)<Tp) THEN
alfaP_T=alfaP*d1(x,y,z)
ELSE IF (d1(x,y,z)>Tp) THEN
alfaP_T=alfaP*Tp
END IF
xmin=mod(x-Rc-1+ifinal,ifinal)+1
xmax=mod(x+Rc-1+ifinal,ifinal)+1
ymin=mod(y-Rc-1+jfinal,jfinal)+1
ymax=mod(y+Rc-1+jfinal,jfinal)+1
zmin=mod(z-Rc-1+kfinal,kfinal)+1
zmax=mod(z+Rc-1+kfinal,kfinal)+1
it=1
f=0
DO WHILE (it<=l)
verifxx=0
verifyy=0
verifzz=0
iii=tipcellsglobal(it,1)
jjj=tipcellsglobal(it,2)
kkk=tipcellsglobal(it,3)
IF (xmax>xmin) THEN
IF (xmin<iii .and. iii<xmax) THEN
verifxx=1
END IF
END IF
IF (ymax>ymin) THEN
IF (ymin<jjj .and. jjj<ymax) THEN
verifyy=1
END IF
END IF
IF (zmax>zmin) THEN
IF (zmin<kkk .and. kkk<zmax) THEN
verifzz=1
END IF
END IF
IF (xmax<xmin) THEN
IF (iii<xmax .or. iii>xmin) THEN
verifxx=1
END IF
END IF
IF (ymax<ymin) THEN
IF (jjj<ymax .or. jjj>ymin) THEN
verifyy=1
END IF
END IF
IF (zmax<zmin) THEN
IF (kkk<zmax .or. kkk>zmin) THEN
verifzz=1
END IF
END IF
IF (verifxx .eq. 1) THEN
IF (verifyy .eq. 1) THEN
IF (verifzz .eq. 1) THEN
f=1
EXIT
END IF
END IF
END IF
it=it+1
END DO
IF (f==0) THEN
IF (d2(x,y,z) > 0.0) THEN
c2(x,y,z)=d2(x,y,z)+delta_t*M*(-deltaphi(x,y,z)+deltaphicubo(x,y,z)-E*deltaphi2(x,y,z))+ &
delta_t*alfaP_T*d2(x,y,z)
ELSE IF (d2(x,y,z) <= 0.0) THEN
c2(x,y,z)=d2(x,y,z)+delta_t*M*(-deltaphi(x,y,z)+deltaphicubo(x,y,z)-E*deltaphi2(x,y,z))
END IF
IF (d2(x,y,z) > 0.0) THEN
c1(x,y,z)=d1(x,y,z)+delta_t*(D*deltatt(x,y,z))-delta_t*alfat*d2(x,y,z)*d1(x,y,z)
ELSE IF (d2(x,y,z) <= 0.0) THEN
c1(x,y,z)=d1(x,y,z)+delta_t*(D*deltatt(x,y,z))
END IF
END IF
IF (f==1) THEN
c2(x,y,z)=((alfaP_T*Rc*4)/(3*sqrt(velocity(it,1)**2+velocity(it,2)**2+velocity(it,3)**2)))
c1(x,y,z)=d1(x,y,z)+delta_t*(D*deltatt(x,y,z))
END IF
END DO
END DO
END DO
i=1
DO WHILE (i<=numpontosfinall)
IF (ligado(i) .eq. 1) THEN
c1(fonte(i,1),fonte(i,2),fonte(i,3))=1.0
END IF
i=i+1
END DO
END SUBROUTINE subupdate
END MODULE update
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